≡ Risteys
R14

Documentation Changelog GitHub Contact & Feedback

Other protozoal intestinal diseases

EFO Endpoint Browser PheWeb

AB1_OTHER_PROTOZOAL

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps

FinnGen

Phenotype data

519870

1. Apply sex-specific rule

None

519870

2. Check conditions

None

519870

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — A07
  • Hospital discharge: ICD-9 — 007.
  • Hospital discharge: ICD-8 — 00[7]
  • Cause of death: ICD-10 — A07
  • Cause of death: ICD-9 — 007.
  • Cause of death: ICD-8 — 00[7]

2 out of 7 registries used, show all original rules.

583

4. Check minimum number of events

None

583

5. Include endpoints

None

583

6. Filter based on genotype QC (FinnGen only)

551

Control definitions (FinnGen only)

Control exclude
AB1_INTESTINAL_INFECTIONS

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF5

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 4130 2179 1912
Only index persons 3443 1892 1551
Unadjusted period prevalence (%)
Whole population 0.06 0.06 0.05
Only index persons 0.06 0.07 0.06
Median age at first event (years)
Whole population 32.48 34.90 29.57
Only index persons 34.41 35.94 32.55

-FinnGen-

Key figures

All Female Male
Number of individuals 551 362 189
Unadjusted period prevalence (%) 0.11 0.13 0.09
Median age at first event (years) 45.40 43.34 49.34

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
583
Matched controls
5830
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
A07.8
ICD-10 Finland
Other specified protozoal intestinal diseases
4185.3
297.3
261
*
A07.1
ICD-10 Finland
Giardiasis [lambliasis]
789.7
132.0
125
*
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
7.2
108.3
210
421
P01AB01
ATC
metronidazole; oral, rectal
6.5
101.2
418
1640
A07.9
ICD-10 Finland
Protozoal intestinal disease, unspecified
+∞
80.1
75
*
00710
ICD-8 Finland
Other protozoal intestinal diseases, Giardiasis
+∞
54.0
51
*
A07.2
ICD-10 Finland
Cryptosporidiosis
+∞
47.6
45
*
K59.1
ICD-10 Finland
Functional diarrhoea
5.5
30.4
62
123
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
2.6
28.8
284
1544
D11
ICPC
Diarrhoea
3.4
28.1
121
420
K58.0
ICD-10 Finland
Irritable bowel syndrome with diarrhoea
4.5
25.6
68
168
UJF30
NOMESCO Finland
Ileoscopy through colon
3.5
23.2
91
296
K58.9
ICD-10 Finland
Irritable bowel syndrome without diarrhoea
5.4
21.0
43
85
A06AC01
ATC
ispaghula (psylla seeds); oral
2.4
18.9
175
890
A02BC05
ATC
esomeprazole; systemic
2.2
18.8
261
1571
A04.7
ICD-10 Finland
Enterocolitis due to Clostridium difficile
103.4
18.7
20
*
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.3
18.6
181
940
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
2.2
18.1
216
1220
UJF32
NOMESCO Finland
Coloscopy
2.4
17.9
164
828
Z2221
NOMESCO Finland
Medical doctor
2.2
17.4
200
1108
K52.9
ICD-10 Finland
Noninfective gastroenteritis and colitis, unspecified
4.7
17.3
41
92
D01
ICPC
Abdominal pain/cramps general
2.6
16.8
108
461
C10AC01
ATC
colestyramine; oral
6.3
16.5
28
46
A08.4
ICD-10 Finland
Viral intestinal infection, unspecified
7.1
15.8
24
35
Z71.8
ICD-10 Finland
Other specified counselling
2.1
15.8
246
1522
A04
ICPC
Weakness/tiredness general
2.4
14.9
116
540
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
2.5
14.0
101
454
K52.88
ICD-10 Finland
Other specified noninfective gastroenteritis and colitis
5.6
13.6
26
48
00799
ICD-8 Finland
Other protozoal intestinal diseases, Other and unspecified
+∞
13.6
13
*
R07.4
ICD-10 Finland
Chest pain, unspecified
2.1
13.0
169
965
R53
ICD-10 Finland
Malaise and fatigue
2.0
12.4
171
996
J02AC01
ATC
fluconazole; systemic
1.9
12.0
253
1695
Z01.7
ICD-10 Finland
Laboratory examination
2.2
11.8
122
637
K21.9
ICD-10 Finland
Gastro-oesophageal reflux disease without oesophagitis
2.6
11.7
72
299
J01MA02
ATC
ciprofloxacin; systemic
1.9
10.9
210
1356
D96
ICPC
Worms/other parasites
28.6
10.8
14
5
A04.9
ICD-10 Finland
Bacterial intestinal infection, unspecified
61.1
10.7
12
*
Z03
ICD-10 Finland
Medical observation and evaluation for suspected diseases and conditions, ruled out
2.6
10.7
68
287
0071A
ICD-9 Finland
Other protozoal intestinal diseases, Giardiasis
+∞
10.4
10
*
A06.9
ICD-10 Finland
Amoebiasis, unspecified
+∞
10.4
10
*
0093A
ICD-9 Finland
Ill-defined intestinal infections, Diarrhoea of presumed infectious origin
+∞
10.4
10
*
00920
ICD-8 Finland
Diarrhoeal disease, Gastroenteritis (acuta) (infectiosa)
+∞
10.4
10
*
R4110
NOMESCO Finland
Physiotherapy
1.9
10.3
167
1019
ZXD10
NOMESCO Finland
Scheduled procedure
1.8
10.1
219
1460
ZXE00
NOMESCO Finland
One hour or less
1.8
9.8
233
1593
D18
ICPC
Change in faeces/bowel movements
4.3
9.5
24
57
A06
ICD-10 Finland
Amoebiasis
+∞
9.4
9
*
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
2.0
9.4
113
621
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.8
9.3
160
991
R10.1
ICD-10 Finland
Pain localized to upper abdomen
2.0
9.2
116
647
R51.80
ICD-10 Finland
Headache
2.0
9.2
117
656
A02BC02
ATC
pantoprazole; systemic
1.7
9.1
374
2955
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
2.1
9.0
98
518
K30
ICD-10 Finland
Functional dyspepsia
2.2
9.0
77
371
UJF30, ,
SPAT
12.8
8.9
15
12
UJF92
NOMESCO Finland
Capsular endoscopy
5.0
8.9
19
39
E0000UV, ,
ATC
1.7
8.7
249
1777
R19.4
ICD-10 Finland
Change in bowel habit
3.8
8.7
26
70
EB1AA, ,
SPAT
2.5
8.7
55
231
D06
ICPC
Abdominal pain localized other
2.4
8.7
63
282
Z3231
NOMESCO Finland
Registered nurse
1.8
8.7
161
1017
K56.6
ICD-10 Finland
Other and unspecified intestinal obstruction
4.6
8.2
19
42
R83
ICPC
Respiratory infection other
1.7
8.0
187
1257
A02BC01
ATC
omeprazole; systemic
1.8
8.0
151
956
J01MA06
ATC
norfloxacin; oral
2.1
7.8
76
384
M79.6
ICD-10 Finland
Pain in limb
1.6
7.8
254
1860
D12.2
ICD-10 Finland
Benign neoplasm: Ascending colon
4.2
7.6
20
49
A02BA02
ATC
ranitidine; systemic
1.9
7.5
98
551
U01
ICPC
Dysuria/painful urination
2.4
7.5
53
235
A06.8
ICD-10 Finland
Amoebic infection of other sites
81.1
7.4
8
*
Z3226
NOMESCO Finland
Physiotherapist
1.9
7.4
106
616
H01.0
ICD-10 Finland
Blepharitis
2.4
7.3
53
237
A07
ICD-10 Finland
Other protozoal intestinal diseases
+∞
7.3
7
*
00000, ,
ICD-8 Finland
+∞
7.3
7
*
N02AX02
ATC
tramadol; systemic, rectal
1.6
7.2
223
1604
A11
ICPC
Chest pain NOS
2.3
7.2
54
245
N01
ICPC
Headache
1.9
7.2
93
522
R42
ICD-10 Finland
Dizziness and giddiness
1.8
7.1
122
748
A97
ICPC
No disease
1.8
7.0
127
791
K03.80
ICD-10 Finland
Irradiated enamel
2.5
7.0
43
178
H04.10
ICD-10 Finland
Dry eye syndrome
2.0
7.0
74
387
L01
ICPC
Neck symptom/complaint
1.8
7.0
105
619
K51.9
ICD-10 Finland
Ulcerative colitis, unspecified
3.4
6.9
24
72
N06AX11
ATC
mirtazapine; oral
1.6
6.9
193
1354
D19
ICPC
Teeth/gum symptom/complaint
1.6
6.8
200
1419
M01AB05
ATC
diclofenac; systemic, rectal
1.6
6.8
367
3004
J01MA01
ATC
ofloxacin; systemic
2.4
6.7
47
208
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.6
6.4
324
2597
L08
ICPC
Shoulder symptom/complaint
1.7
6.4
131
845
D12.0
ICD-10 Finland
Benign neoplasm: Caecum
5.6
6.3
17
31
J01FA10
ATC
azithromycin; systemic
1.6
6.3
343
2787
A07.0
ICD-10 Finland
Balantidiasis
+∞
6.3
6
*
0078A
ICD-9 Finland
Other protozoal intestinal diseases, Other specified protozoal intestinal diseases[CRYPTOSPORIDIOSIS]
+∞
6.3
6
*
H93.1
ICD-10 Finland
Tinnitus
2.3
6.3
45
201
L92
ICPC
Shoulder syndrome
4.0
6.2
17
43
K29.7
ICD-10 Finland
Gastritis, unspecified
3.4
6.2
22
67
J01FA06
ATC
roxithromycin; oral
1.6
6.1
216
1590
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
1.9
6.1
88
510
K44.9
ICD-10 Finland
Diaphragmatic hernia without obstruction or gangrene
2.4
6.1
42
184
A06AD11
ATC
lactulose; oral
2.0
6.1
66
348
Z76.0
ICD-10 Finland
Issue of repeat prescription
1.6
6.1
167
1160
XQ800
NOMESCO Finland
Prick test
2.2
6.0
51
244
A07EA06
ATC
budesonide; oral, local oral
2.9
6.0
27
95

TimeCodeWAS

↥

TODO / Current known limitations:

  • Only showing the top 300 codes, because showing all (sometimes 20k) makes the page too slow.
  • Legend / how to read the glyphs.
  • Show details (e.g. Fisher or Chi-square test, LR+, etc.) when clicking on a row.
  • Explanation on the underlying data / how the TimeCodeWAS is done (e.g. matched cases / controls, eligibility).
  • Download CSV.
  • No filters and sorters.
  • Limited amount of endpoints (~400) having TimeCodeWAS data.
  • Cross-links to Risteys lab test pages for lab test codes.
OMOP concept
ln(OR)
%cases with code / %controls with code
2×2 table
Ova and parasites identified in Stool by Light microscopy
10704-5 [3003327]
1.7e+00
5.4e+00
—
1.0e+50
—
5.8e+00
3.2e+00
cases:4.95%
controls:0.95%
cases:32.28%
controls:0.22%
—
—
cases:2.18%
controls:0.00%
—
—
cases:35.60%
controls:0.17%
cases:17.28%
controls:0.89%
25
48
480
4981
163
11
342
5018
—
11
0
494
5029
—
173
8
313
4840
70
36
335
4031
Calprotectin [Mass/mass] in Stool
38445-3 [3048689]
1.1e+00
2.9e+00
4.7e+00
1.0e+50
2.7e+00
1.8e+00
1.4e+00
cases:10.30%
controls:3.82%
cases:21.19%
controls:1.49%
cases:11.88%
controls:0.12%
cases:0.99%
controls:0.00%
cases:1.99%
controls:0.14%
cases:9.47%
controls:1.63%
cases:12.59%
controls:3.37%
52
192
453
4837
107
75
398
4954
60
6
445
5023
5
0
500
5029
10
7
493
5008
46
79
440
4769
51
137
354
3930
metronidazole; oral, rectal
P01AB01 [21604857]
6.9e-01
3.4e+00
3.7e+00
1.0e+50
3.9e+00
1.6e+00
1.0e+00
cases:14.06%
controls:7.56%
cases:44.55%
controls:2.53%
cases:5.15%
controls:0.14%
cases:6.53%
controls:0.00%
cases:9.94%
controls:0.22%
cases:9.05%
controls:2.06%
cases:15.56%
controls:6.15%
71
380
434
4649
225
127
280
4902
26
7
479
5022
33
0
472
5029
50
11
453
5004
44
100
442
4748
63
250
342
3817
IgA [Mass/volume] in Serum or Plasma
2458-8 [3007164]
7.3e-01
2.3e+00
3.5e+00
—
2.7e+00
1.7e+00
8.1e-01
cases:10.50%
controls:5.35%
cases:15.05%
controls:1.71%
cases:8.51%
controls:0.28%
—
—
cases:1.79%
controls:0.12%
cases:7.41%
controls:1.51%
cases:11.85%
controls:5.66%
53
269
452
4760
76
86
429
4943
43
14
462
5015
—
9
6
494
5009
36
73
450
4775
48
230
357
3837
Tissue transglutaminase IgA Ab [Units/volume] in Serum
31017-7 [3019050]
7.9e-01
2.2e+00
3.7e+00
—
2.1e+00
1.2e+00
7.1e-01
cases:12.48%
controls:6.08%
cases:16.24%
controls:2.13%
cases:8.12%
controls:0.22%
—
—
cases:1.39%
controls:0.18%
cases:6.38%
controls:2.06%
cases:13.58%
controls:7.16%
63
306
442
4723
82
107
423
4922
41
11
464
5018
—
7
9
496
5006
31
100
455
4748
55
291
350
3776
C reactive protein [Mass/volume] in Serum or Plasma
1988-5 [3020460]
1.8e-01
9.4e-01
2.7e+00
4.0e+00
1.4e+00
7.9e-01
7.2e-01
cases:39.01%
controls:34.90%
cases:39.80%
controls:20.52%
cases:33.66%
controls:3.46%
cases:7.72%
controls:0.16%
cases:13.72%
controls:3.69%
cases:36.01%
controls:20.30%
cases:61.23%
controls:43.50%
197
1755
308
3274
201
1032
304
3997
170
174
335
4855
39
8
466
5021
69
185
434
4830
175
984
311
3864
248
1769
157
2298
Gastroenterology
10 [38004455]
6.6e-01
1.9e+00
2.7e+00
—
2.4e+00
2.0e+00
6.7e-01
cases:9.31%
controls:5.03%
cases:12.28%
controls:2.13%
cases:8.12%
controls:0.58%
—
—
cases:6.16%
controls:0.62%
cases:17.08%
controls:2.66%
cases:11.11%
controls:6.00%
47
253
458
4776
62
107
443
4922
41
29
464
5000
—
31
31
472
4984
83
129
403
4719
45
244
360
3823
Normoblasts [#/volume] in Blood
715-3 [3021589]
5.0e-01
4.8e-01
2.9e+00
3.1e+00
1.3e+00
7.0e-01
5.2e-01
cases:17.23%
controls:11.25%
cases:13.47%
controls:8.75%
cases:23.56%
controls:1.63%
cases:2.18%
controls:0.10%
cases:6.76%
controls:1.91%
cases:17.08%
controls:9.26%
cases:24.69%
controls:16.33%
87
566
418
4463
68
440
437
4589
119
82
386
4947
11
5
494
5024
34
96
469
4919
83
449
403
4399
100
664
305
3403
Coloscopy
UJF32 [2001305029]
7.1e-01
2.0e+00
2.5e+00
—
2.3e+00
1.8e+00
3.9e-01
cases:6.73%
controls:3.42%
cases:4.75%
controls:0.70%
cases:1.19%
controls:0.10%
—
—
cases:1.19%
controls:0.12%
cases:5.35%
controls:0.91%
cases:4.69%
controls:3.22%
34
172
471
4857
24
35
481
4994
6
5
499
5024
—
6
6
497
5009
26
44
460
4804
19
131
386
3936
Outpatient Visit
OP [9202]
4.5e-01
4.6e-01
7.3e-01
4.8e+00
1.1e+00
1.1e+00
4.9e-01
cases:81.19%
controls:73.28%
cases:62.57%
controls:51.26%
cases:19.01%
controls:10.12%
cases:39.60%
controls:0.52%
cases:26.44%
controls:10.41%
cases:74.90%
controls:49.55%
cases:84.94%
controls:77.55%
410
3685
95
1344
316
2578
189
2451
96
509
409
4520
200
26
305
5003
133
522
370
4493
364
2402
122
2446
344
3154
61
913
Celiac disease serology panel - Serum
94494-2 [36660697]
8.8e-01
2.4e+00
3.8e+00
—
—
1.9e+00
7.7e-01
cases:4.55%
controls:1.95%
cases:6.14%
controls:0.58%
cases:5.74%
controls:0.14%
—
—
—
—
cases:3.70%
controls:0.56%
cases:4.69%
controls:2.24%
23
98
482
4931
31
29
474
5000
29
7
476
5022
—
—
18
27
468
4821
19
91
386
3976
Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
54067-4 [3051552]
1.1e+00
3.2e+00
—
1.0e+50
—
2.6e+00
1.9e+00
cases:3.17%
controls:1.05%
cases:7.52%
controls:0.32%
—
—
cases:1.98%
controls:0.00%
—
—
cases:3.91%
controls:0.31%
cases:6.17%
controls:0.96%
16
53
489
4976
38
16
467
5013
—
10
0
495
5029
—
19
15
467
4833
25
39
380
4028
Other and unspecified abdominal pain
R10.4 [45568113]
1.1e+00
2.0e+00
2.9e+00
1.0e+50
—
1.7e+00
1.1e+00
cases:14.46%
controls:5.17%
cases:13.66%
controls:2.11%
cases:2.77%
controls:0.16%
cases:1.39%
controls:0.00%
—
—
cases:8.23%
controls:1.59%
cases:17.53%
controls:6.81%
73
260
432
4769
69
106
436
4923
14
8
491
5021
7
0
498
5029
—
40
77
446
4771
71
277
334
3790
Neutrophils [#/volume] in Blood by Automated count
751-8 [3013650]
3.7e-01
6.3e-01
2.6e+00
2.8e+00
1.1e+00
9.3e-01
7.4e-01
cases:21.19%
controls:15.69%
cases:16.83%
controls:9.74%
cases:23.17%
controls:2.23%
cases:1.98%
controls:0.12%
cases:6.96%
controls:2.53%
cases:21.40%
controls:9.67%
cases:31.36%
controls:17.85%
107
789
398
4240
85
490
420
4539
117
112
388
4917
10
6
495
5023
35
127
468
4888
104
469
382
4379
127
726
278
3341
Sodium [Moles/volume] in Serum or Plasma
2951-2 [3019550]
2.5e-01
5.0e-01
2.3e+00
3.7e+00
1.2e+00
5.2e-01
4.8e-01
cases:40.00%
controls:34.22%
cases:33.86%
controls:23.64%
cases:29.50%
controls:4.08%
cases:8.12%
controls:0.22%
cases:12.33%
controls:3.97%
cases:34.16%
controls:23.54%
cases:58.02%
controls:46.10%
202
1721
303
3308
171
1189
334
3840
149
205
356
4824
41
11
464
5018
62
199
441
4816
166
1141
320
3707
235
1875
170
2192
Potassium [Moles/volume] in Serum or Plasma
2823-3 [3023103]
2.1e-01
4.8e-01
2.3e+00
3.7e+00
1.2e+00
5.1e-01
4.9e-01
cases:39.60%
controls:34.60%
cases:33.66%
controls:23.96%
cases:29.31%
controls:4.16%
cases:8.12%
controls:0.22%
cases:12.33%
controls:4.07%
cases:34.36%
controls:23.89%
cases:58.52%
controls:46.42%
200
1740
305
3289
170
1205
335
3824
148
209
357
4820
41
11
464
5018
62
204
441
4811
167
1158
319
3690
237
1888
168
2179
Erythrocyte [DistWidth] in Red Blood Cells
30385-9 [3002385]
3.9e-01
6.6e-01
2.2e+00
3.0e+00
9.8e-01
6.7e-01
5.3e-01
cases:38.22%
controls:29.55%
cases:36.04%
controls:22.59%
cases:29.90%
controls:4.69%
cases:5.35%
controls:0.28%
cases:12.13%
controls:4.93%
cases:36.01%
controls:22.32%
cases:54.32%
controls:41.21%
193
1486
312
3543
182
1136
323
3893
151
236
354
4793
27
14
478
5015
61
247
442
4768
175
1082
311
3766
220
1676
185
2391
Other gastroenteritis and colitis of infectious and unspecified origin
A09 [45605189]
1.7e+00
3.1e+00
—
1.0e+50
—
2.2e+00
1.4e+00
cases:5.35%
controls:0.99%
cases:9.70%
controls:0.50%
—
—
cases:3.37%
controls:0.00%
—
—
cases:5.56%
controls:0.66%
cases:7.90%
controls:2.14%
27
50
478
4979
49
25
456
5004
—
17
0
488
5029
—
27
32
459
4816
32
87
373
3980
HIV 1 and 2 tests - Meaningful Use set
75622-1 [46235355]
4.9e-01
7.4e-01
4.0e+00
—
1.8e+00
1.1e+00
7.4e-01
cases:10.89%
controls:6.94%
cases:6.34%
controls:3.14%
cases:13.86%
controls:0.30%
—
—
cases:2.19%
controls:0.36%
cases:6.58%
controls:2.39%
cases:15.31%
controls:7.94%
55
349
450
4680
32
158
473
4871
70
15
435
5014
—
11
18
492
4997
32
116
454
4732
62
323
343
3744
Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M
62238-1 [40764999]
3.5e-01
5.9e-01
2.3e+00
3.0e+00
9.7e-01
5.9e-01
4.8e-01
cases:34.46%
controls:26.96%
cases:32.48%
controls:21.02%
cases:27.13%
controls:3.68%
cases:4.36%
controls:0.22%
cases:9.94%
controls:4.01%
cases:31.89%
controls:20.67%
cases:50.86%
controls:39.05%
174
1356
331
3673
164
1057
341
3972
137
185
368
4844
22
11
483
5018
50
201
453
4814
155
1002
331
3846
206
1588
199
2479
Internal Medicine
11 [38004456]
4.9e-01
1.1e+00
2.6e+00
1.0e+50
2.0e+00
1.2e+00
8.6e-01
cases:23.17%
controls:15.65%
cases:17.43%
controls:6.62%
cases:9.11%
controls:0.78%
cases:20.59%
controls:0.00%
cases:6.56%
controls:0.96%
cases:16.46%
controls:5.38%
cases:26.91%
controls:13.47%
117
787
388
4242
88
333
417
4696
46
39
459
4990
104
0
401
5029
33
48
470
4967
80
261
406
4587
109
548
296
3519
Infectious Disease
44 [38004484]
4.6e-01
1.8e+00
—
1.0e+50
—
4.7e+00
1.8e+00
cases:2.38%
controls:1.51%
cases:5.15%
controls:0.91%
—
—
cases:55.05%
controls:0.00%
—
—
cases:48.77%
controls:0.89%
cases:9.88%
controls:1.87%
12
76
493
4953
26
46
479
4983
—
278
0
227
5029
—
237
43
249
4805
40
76
365
3991
Creatinine [Moles/volume] in Serum or Plasma
14682-9 [3020564]
1.6e-01
5.3e-01
2.1e+00
3.6e+00
9.9e-01
5.0e-01
3.8e-01
cases:42.77%
controls:38.91%
cases:41.19%
controls:29.19%
cases:32.67%
controls:5.47%
cases:8.12%
controls:0.24%
cases:13.92%
controls:5.66%
cases:40.53%
controls:29.21%
cases:62.47%
controls:53.36%
216
1957
289
3072
208
1468
297
3561
165
275
340
4754
41
12
464
5017
70
284
433
4731
197
1416
289
3432
253
2170
152
1897
Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1742-6 [3006923]
1.6e-01
5.8e-01
2.2e+00
3.8e+00
8.0e-01
4.7e-01
3.4e-01
cases:41.78%
controls:37.94%
cases:40.00%
controls:27.12%
cases:31.49%
controls:4.65%
cases:4.36%
controls:0.10%
cases:10.14%
controls:4.85%
cases:37.86%
controls:27.62%
cases:60.00%
controls:51.64%
211
1908
294
3121
202
1364
303
3665
159
234
346
4795
22
5
483
5024
51
243
452
4772
184
1339
302
3509
243
2100
162
1967
Monocytes/Leukocytes in Blood
26485-3 [3019069]
5.0e-01
8.3e-01
3.1e+00
—
1.5e+00
1.1e+00
8.4e-01
cases:19.21%
controls:12.61%
cases:15.64%
controls:7.46%
cases:22.97%
controls:1.37%
—
—
cases:6.76%
controls:1.58%
cases:19.34%
controls:7.08%
cases:29.14%
controls:15.02%
97
634
408
4395
79
375
426
4654
116
69
389
4960
—
34
79
469
4936
94
343
392
4505
118
611
287
3456
Neutrophils/Leukocytes in Blood
26511-6 [3018010]
5.0e-01
9.0e-01
3.1e+00
—
1.4e+00
1.1e+00
8.3e-01
cases:19.60%
controls:12.93%
cases:16.44%
controls:7.42%
cases:23.56%
controls:1.33%
—
—
cases:6.56%
controls:1.64%
cases:18.72%
controls:7.10%
cases:29.38%
controls:15.39%
99
650
406
4379
83
373
422
4656
119
67
386
4962
—
33
82
470
4933
91
344
395
4504
119
626
286
3441
Basophils/Leukocytes in Blood
30180-4 [3022096]
4.9e-01
8.3e-01
3.1e+00
—
1.5e+00
1.2e+00
8.2e-01
cases:19.01%
controls:12.59%
cases:15.45%
controls:7.38%
cases:23.17%
controls:1.37%
—
—
cases:6.76%
controls:1.56%
cases:19.34%
controls:7.01%
cases:28.89%
controls:15.22%
96
633
409
4396
78
371
427
4658
117
69
388
4960
—
34
78
469
4937
94
340
392
4508
117
619
288
3448
Eosinophils/Leukocytes in Blood
26450-7 [3006504]
4.9e-01
8.2e-01
3.1e+00
—
1.5e+00
1.1e+00
8.3e-01
cases:19.01%
controls:12.59%
cases:15.45%
controls:7.42%
cases:22.97%
controls:1.37%
—
—
cases:6.76%
controls:1.58%
cases:19.14%
controls:6.99%
cases:28.89%
controls:15.05%
96
633
409
4396
78
373
427
4656
116
69
389
4960
—
34
79
469
4936
93
339
393
4509
117
612
288
3455
Lymphocytes/Leukocytes in Blood
26478-8 [3002030]
5.0e-01
9.0e-01
3.1e+00
—
1.5e+00
1.1e+00
8.5e-01
cases:19.80%
controls:13.04%
cases:16.63%
controls:7.54%
cases:23.17%
controls:1.39%
—
—
cases:6.76%
controls:1.64%
cases:18.72%
controls:7.32%
cases:30.12%
controls:15.59%
100
656
405
4373
84
379
421
4650
117
70
388
4959
—
34
82
469
4933
91
355
395
4493
122
634
283
3433
Monocytes [#/volume] in Blood
26484-6 [3001604]
4.4e-01
8.2e-01
3.0e+00
—
1.5e+00
1.0e+00
7.5e-01
cases:19.21%
controls:13.22%
cases:16.24%
controls:7.87%
cases:23.56%
controls:1.45%
—
—
cases:6.76%
controls:1.64%
cases:19.55%
controls:7.88%
cases:29.88%
controls:16.74%
97
665
408
4364
82
396
423
4633
119
73
386
4956
—
34
82
469
4933
95
382
391
4466
121
681
284
3386
Basophils [#/volume] in Blood
26444-0 [3006315]
4.4e-01
8.1e-01
3.0e+00
—
1.5e+00
1.0e+00
7.5e-01
cases:19.21%
controls:13.28%
cases:16.04%
controls:7.85%
cases:23.56%
controls:1.45%
—
—
cases:6.76%
controls:1.64%
cases:19.55%
controls:7.90%
cases:29.88%
controls:16.77%
97
668
408
4361
81
395
424
4634
119
73
386
4956
—
34
82
469
4933
95
383
391
4465
121
682
284
3385
Differential panel, method unspecified - Blood
69738-3 [42870588]
4.3e-01
6.7e-01
3.3e+00
—
1.5e+00
1.2e+00
8.1e-01
cases:12.28%
controls:8.33%
cases:9.70%
controls:5.19%
cases:19.01%
controls:0.86%
—
—
cases:4.17%
controls:1.00%
cases:15.02%
controls:4.91%
cases:19.51%
controls:9.71%
62
419
443
4610
49
261
456
4768
96
43
409
4986
—
21
50
482
4965
73
238
413
4610
79
395
326
3672
Lymphocytes [#/volume] in Blood
26474-7 [3019198]
4.3e-01
8.6e-01
3.0e+00
—
1.4e+00
9.7e-01
7.7e-01
cases:20.00%
controls:14.04%
cases:17.03%
controls:8.01%
cases:23.56%
controls:1.47%
—
—
cases:6.76%
controls:1.71%
cases:18.93%
controls:8.13%
cases:30.86%
controls:17.06%
101
706
404
4323
86
403
419
4626
119
74
386
4955
—
34
86
469
4929
92
394
394
4454
125
694
280
3373
Bacteria identified in Stool by Culture
625-4 [3025941]
1.0e+00
3.1e+00
—
1.0e+50
—
2.1e+00
1.2e+00
cases:3.96%
controls:1.49%
cases:5.54%
controls:0.26%
—
—
cases:1.39%
controls:0.00%
—
—
cases:2.06%
controls:0.25%
cases:3.70%
controls:1.13%
20
75
485
4954
28
13
477
5016
—
7
0
498
5029
—
10
12
476
4836
15
46
390
4021
Eosinophils [#/volume] in Blood
26449-9 [3013115]
4.5e-01
7.8e-01
3.0e+00
—
1.4e+00
1.1e+00
7.1e-01
cases:20.00%
controls:13.80%
cases:16.24%
controls:8.19%
cases:23.56%
controls:1.49%
—
—
cases:6.76%
controls:1.75%
cases:20.58%
controls:8.07%
cases:29.88%
controls:17.26%
101
694
404
4335
82
412
423
4617
119
75
386
4954
—
34
88
469
4927
100
391
386
4457
121
702
284
3365
MCHC [Entitic Mass/volume] in Red Blood Cells
28540-3 [3003338]
2.1e-01
6.5e-01
2.0e+00
3.1e+00
8.9e-01
5.8e-01
3.4e-01
cases:39.60%
controls:34.60%
cases:37.62%
controls:23.86%
cases:28.71%
controls:4.93%
cases:5.15%
controls:0.24%
cases:11.33%
controls:4.99%
cases:36.01%
controls:23.95%
cases:53.33%
controls:44.90%
200
1740
305
3289
190
1200
315
3829
145
248
360
4781
26
12
479
5017
57
250
446
4765
175
1161
311
3687
216
1826
189
2241
Laboratory Visit
OMOP4822461 [32036]
5.6e-02
3.5e-01
1.9e+00
3.4e+00
9.9e-01
4.7e-01
2.1e-01
cases:52.87%
controls:51.48%
cases:55.84%
controls:47.03%
cases:51.09%
controls:13.10%
cases:13.86%
controls:0.52%
cases:29.22%
controls:13.26%
cases:59.47%
controls:47.79%
cases:72.35%
controls:68.06%
267
2589
238
2440
282
2365
223
2664
258
659
247
4370
70
26
435
5003
147
665
356
4350
289
2317
197
2531
293
2768
112
1299
Leukocytes [#/volume] in Blood
26464-8 [3010813]
7.3e-02
5.6e-01
2.0e+00
3.3e+00
9.0e-01
4.5e-01
3.1e-01
cases:47.92%
controls:46.11%
cases:49.31%
controls:35.79%
cases:36.04%
controls:7.32%
cases:8.32%
controls:0.34%
cases:16.50%
controls:7.46%
cases:46.71%
controls:35.89%
cases:67.90%
controls:60.81%
242
2319
263
2710
249
1800
256
3229
182
368
323
4661
42
17
463
5012
83
374
420
4641
227
1740
259
3108
275
2473
130
1594
Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
6768-6 [3035995]
4.1e-01
1.0e+00
2.9e+00
—
1.3e+00
9.3e-01
5.1e-01
cases:27.72%
controls:20.34%
cases:29.90%
controls:13.26%
cases:27.92%
controls:2.05%
—
—
cases:8.75%
controls:2.43%
cases:25.93%
controls:12.11%
cases:38.27%
controls:27.10%
140
1023
365
4006
151
667
354
4362
141
103
364
4926
—
44
122
459
4893
126
587
360
4261
155
1102
250
2965
Helicobacter pylori Ag [Presence] in Stool
31843-6 [3013139]
9.5e-01
2.6e+00
—
—
—
2.3e+00
1.3e+00
cases:4.36%
controls:1.73%
cases:6.34%
controls:0.52%
—
—
—
—
—
—
cases:2.06%
controls:0.21%
cases:4.69%
controls:1.35%
22
87
483
4942
32
26
473
5003
—
—
—
10
10
476
4838
19
55
386
4012
Hematocrit [Volume Fraction] of Blood by calculation
20570-8 [3009542]
7.7e-02
5.5e-01
2.0e+00
3.2e+00
8.9e-01
4.5e-01
3.1e-01
cases:47.92%
controls:46.01%
cases:48.91%
controls:35.69%
cases:35.84%
controls:7.24%
cases:7.72%
controls:0.34%
cases:16.30%
controls:7.44%
cases:46.71%
controls:35.81%
cases:67.90%
controls:60.81%
242
2314
263
2715
247
1795
258
3234
181
364
324
4665
39
17
466
5012
82
373
421
4642
227
1736
259
3112
275
2473
130
1594
MCV [Entitic mean volume] in Red Blood Cells
30428-7 [3024731]
6.9e-02
5.5e-01
2.0e+00
3.2e+00
8.9e-01
4.5e-01
3.1e-01
cases:47.72%
controls:46.01%
cases:48.91%
controls:35.69%
cases:35.84%
controls:7.26%
cases:7.72%
controls:0.34%
cases:16.30%
controls:7.44%
cases:46.71%
controls:35.83%
cases:67.90%
controls:60.73%
241
2314
264
2715
247
1795
258
3234
181
365
324
4664
39
17
466
5012
82
373
421
4642
227
1737
259
3111
275
2470
130
1597
Erythrocytes [#/volume] in Blood
26453-1 [3026361]
7.7e-02
5.4e-01
2.0e+00
3.2e+00
8.9e-01
4.5e-01
3.1e-01
cases:47.92%
controls:45.99%
cases:48.91%
controls:35.73%
cases:35.84%
controls:7.26%
cases:7.72%
controls:0.34%
cases:16.30%
controls:7.44%
cases:46.71%
controls:35.83%
cases:67.90%
controls:60.81%
242
2313
263
2716
247
1797
258
3232
181
365
324
4664
39
17
466
5012
82
373
421
4642
227
1737
259
3111
275
2473
130
1594
Platelets [#/volume] in Blood
26515-7 [3007461]
7.4e-02
5.4e-01
2.0e+00
3.2e+00
8.9e-01
4.5e-01
3.2e-01
cases:47.72%
controls:45.87%
cases:48.71%
controls:35.57%
cases:35.84%
controls:7.24%
cases:7.72%
controls:0.34%
cases:16.30%
controls:7.44%
cases:46.50%
controls:35.73%
cases:67.90%
controls:60.63%
241
2307
264
2722
246
1789
259
3240
181
364
324
4665
39
17
466
5012
82
373
421
4642
226
1732
260
3116
275
2466
130
1601
Hemoglobin [Mass/volume] in Blood
718-7 [3000963]
7.2e-02
5.4e-01
2.0e+00
3.2e+00
8.8e-01
4.4e-01
3.2e-01
cases:47.92%
controls:46.13%
cases:48.91%
controls:35.71%
cases:36.04%
controls:7.26%
cases:7.72%
controls:0.34%
cases:16.30%
controls:7.50%
cases:46.71%
controls:35.97%
cases:68.15%
controls:60.88%
242
2320
263
2709
247
1796
258
3233
182
365
323
4664
39
17
466
5012
82
376
421
4639
227
1744
259
3104
276
2476
129
1591
MCH [Entitic mass]
28539-5 [3035941]
7.1e-02
5.4e-01
2.0e+00
3.2e+00
8.9e-01
4.5e-01
3.1e-01
cases:47.72%
controls:45.95%
cases:48.71%
controls:35.61%
cases:35.64%
controls:7.26%
cases:7.72%
controls:0.34%
cases:16.30%
controls:7.44%
cases:46.50%
controls:35.77%
cases:67.90%
controls:60.78%
241
2311
264
2718
246
1791
259
3238
180
365
325
4664
39
17
466
5012
82
373
421
4642
226
1734
260
3114
275
2472
130
1595
Colonoscopy Study observation
28023-0 [3022145]
1.1e+00
2.1e+00
—
1.0e+50
—
2.5e+00
1.3e+00
cases:5.54%
controls:1.89%
cases:5.15%
controls:0.64%
—
—
cases:1.19%
controls:0.00%
—
—
cases:7.20%
controls:0.66%
cases:8.40%
controls:2.53%
28
95
477
4934
26
32
479
4997
—
6
0
499
5029
—
35
32
451
4816
34
103
371
3964
Esophagoscopy, gastroscopy and duodenoscopy
UJD10 [2001304788]
8.7e-01
1.5e+00
2.8e+00
—
—
1.7e+00
5.0e-01
cases:7.72%
controls:3.38%
cases:5.35%
controls:1.21%
cases:2.57%
controls:0.16%
—
—
—
—
cases:5.76%
controls:1.13%
cases:5.43%
controls:3.37%
39
170
466
4859
27
61
478
4968
13
8
492
5021
—
—
28
55
458
4793
22
137
383
3930
Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method
4537-7 [3013707]
4.0e-01
9.3e-01
3.1e+00
—
1.1e+00
7.5e-01
6.0e-01
cases:27.72%
controls:20.50%
cases:22.77%
controls:10.42%
cases:21.98%
controls:1.23%
—
—
cases:4.37%
controls:1.56%
cases:19.75%
controls:10.38%
cases:38.27%
controls:25.33%
140
1031
365
3998
115
524
390
4505
111
62
394
4967
—
22
78
481
4937
96
503
390
4345
155
1030
250
3037
Functional diarrhoea
K59.1 [45543327]
1.2e+00
2.9e+00
—
—
—
2.0e+00
2.0e+00
cases:1.78%
controls:0.54%
cases:3.37%
controls:0.20%
—
—
—
—
—
—
cases:1.23%
controls:0.17%
cases:3.70%
controls:0.54%
9
27
496
5002
17
10
488
5019
—
—
—
6
8
480
4840
15
22
390
4045
Upper gastrointestinal surgery
106 [44777669]
7.0e-01
9.7e-01
1.6e+00
1.0e+50
1.6e+00
1.2e+00
7.7e-01
cases:14.26%
controls:7.60%
cases:7.72%
controls:3.06%
cases:2.18%
controls:0.46%
cases:0.99%
controls:0.00%
cases:2.19%
controls:0.44%
cases:9.05%
controls:3.01%
cases:15.56%
controls:7.89%
72
382
433
4647
39
154
466
4875
11
23
494
5006
5
0
500
5029
11
22
492
4993
44
146
442
4702
63
321
342
3746
Irritable bowel syndrome with diarrhoea
K58.0 [45596336]
6.6e-01
2.2e+00
—
—
—
2.4e+00
2.0e+00
cases:1.19%
controls:0.62%
cases:2.18%
controls:0.24%
—
—
—
—
—
—
cases:3.70%
controls:0.35%
cases:3.95%
controls:0.54%
6
31
499
4998
11
12
494
5017
—
—
—
18
17
468
4831
16
22
389
4045
Abnormal weight loss
R63.4 [45568144]
—
2.5e+00
—
—
—
2.2e+00
1.9e+00
—
—
cases:1.19%
controls:0.10%
—
—
—
—
—
—
cases:1.44%
controls:0.17%
cases:1.98%
controls:0.30%
—
6
5
499
5024
—
—
—
7
8
479
4840
8
12
397
4055
Person consulting for explanation of investigation findings
Z71.2 [45552100]
9.1e-01
1.2e+00
2.3e+00
—
—
1.2e+00
8.6e-01
cases:11.29%
controls:4.85%
cases:6.73%
controls:2.07%
cases:2.18%
controls:0.22%
—
—
—
—
cases:6.58%
controls:2.04%
cases:15.06%
controls:6.96%
57
244
448
4785
34
104
471
4925
11
11
494
5018
—
—
32
99
454
4749
61
283
344
3784
Bilirubin.conjugated [Moles/volume] in Serum or Plasma
29760-6 [3005772]
4.8e-01
1.6e+00
—
—
2.2e+00
1.4e+00
1.2e+00
cases:3.56%
controls:2.23%
cases:4.36%
controls:0.87%
—
—
—
—
cases:1.39%
controls:0.16%
cases:2.88%
controls:0.72%
cases:6.91%
controls:2.16%
18
112
487
4917
22
44
483
4985
—
—
7
8
496
5007
14
35
472
4813
28
88
377
3979
Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
1805-1 [3016417]
1.2e+00
1.8e+00
—
—
—
1.8e+00
1.5e+00
cases:4.16%
controls:1.35%
cases:4.95%
controls:0.84%
—
—
—
—
—
—
cases:3.50%
controls:0.62%
cases:7.41%
controls:1.82%
21
68
484
4961
25
42
480
4987
—
—
—
17
30
469
4818
30
74
375
3993
Bilirubin.total [Moles/volume] in Serum or Plasma
14631-6 [3006140]
2.8e-01
1.1e+00
2.0e+00
—
1.5e+00
1.0e+00
4.6e-01
cases:13.47%
controls:10.56%
cases:15.05%
controls:5.81%
cases:6.53%
controls:0.89%
—
—
cases:4.77%
controls:1.06%
cases:13.17%
controls:5.22%
cases:20.25%
controls:13.82%
68
531
437
4498
76
292
429
4737
33
45
472
4984
—
24
53
479
4962
64
253
422
4595
82
562
323
3505
Salmonella sp identified in Stool by Organism specific culture
20955-1 [3004716]
1.2e+00
2.8e+00
—
—
—
2.1e+00
8.1e-01
cases:4.95%
controls:1.57%
cases:6.14%
controls:0.40%
—
—
—
—
—
—
cases:2.06%
controls:0.25%
cases:2.72%
controls:1.23%
25
79
480
4950
31
20
474
5009
—
—
—
10
12
476
4836
11
50
394
4017
Albumin [Mass/volume] in Serum or Plasma
1751-7 [3024561]
3.6e-01
8.7e-01
1.8e+00
—
1.7e+00
1.0e+00
6.6e-01
cases:12.08%
controls:8.75%
cases:10.89%
controls:4.85%
cases:4.16%
controls:0.72%
—
—
cases:3.78%
controls:0.72%
cases:12.14%
controls:4.79%
cases:20.49%
controls:11.80%
61
440
444
4589
55
244
450
4785
21
36
484
4993
—
19
36
484
4979
59
232
427
4616
83
480
322
3587
MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
72872-5 [43534045]
9.2e-01
2.6e+00
—
—
—
2.3e+00
7.5e-01
cases:3.76%
controls:1.53%
cases:5.35%
controls:0.42%
—
—
—
—
—
—
cases:3.09%
controls:0.31%
cases:2.47%
controls:1.18%
19
77
486
4952
27
21
478
5008
—
—
—
15
15
471
4833
10
48
395
4019
Case Management Agency
251B00000X [38004193]
1.8e-01
4.1e-01
7.0e-01
3.8e+00
3.8e-01
3.9e-01
1.7e-01
cases:74.06%
controls:70.43%
cases:73.27%
controls:64.45%
cases:42.18%
controls:26.55%
cases:43.37%
controls:1.61%
cases:35.59%
controls:27.48%
cases:74.49%
controls:66.34%
cases:85.19%
controls:82.89%
374
3542
131
1487
370
3241
135
1788
213
1335
292
3694
219
81
286
4948
179
1378
324
3637
362
3216
124
1632
345
3371
60
696
Abdominal pain/cramps general
D01 [2002000300]
9.5e-01
2.3e+00
—
—
—
1.3e+00
1.2e+00
cases:4.36%
controls:1.73%
cases:4.75%
controls:0.50%
—
—
—
—
—
—
cases:2.47%
controls:0.68%
cases:5.93%
controls:1.92%
22
87
483
4942
24
25
481
5004
—
—
—
12
33
474
4815
24
78
381
3989
Stomach Pathology biopsy report
66114-0 [40768797]
1.2e+00
1.5e+00
—
—
—
2.0e+00
1.0e+00
cases:6.93%
controls:2.29%
cases:4.16%
controls:0.91%
—
—
—
—
—
—
cases:5.14%
controls:0.74%
cases:6.67%
controls:2.53%
35
115
470
4914
21
46
484
4983
—
—
—
25
36
461
4812
27
103
378
3964
loperamide; oral
A07DA03 [21600646]
1.1e+00
1.7e+00
—
—
—
2.2e+00
1.9e+00
cases:2.57%
controls:0.91%
cases:2.38%
controls:0.46%
—
—
—
—
—
—
cases:3.50%
controls:0.41%
cases:4.69%
controls:0.76%
13
46
492
4983
12
23
493
5006
—
—
—
17
20
469
4828
19
31
386
4036
loperamide oxide; oral
A07DA05 [21600648]
1.1e+00
1.7e+00
—
—
—
2.2e+00
1.9e+00
cases:2.57%
controls:0.91%
cases:2.38%
controls:0.46%
—
—
—
—
—
—
cases:3.50%
controls:0.41%
cases:4.69%
controls:0.76%
13
46
492
4983
12
23
493
5006
—
—
—
17
20
469
4828
19
31
386
4036
Diarrhoea
D11 [2002000310]
6.7e-01
2.3e+00
—
—
—
2.0e+00
1.3e+00
cases:3.17%
controls:1.65%
cases:5.35%
controls:0.56%
—
—
—
—
—
—
cases:3.29%
controls:0.45%
cases:5.43%
controls:1.60%
16
83
489
4946
27
28
478
5001
—
—
—
16
22
470
4826
22
65
383
4002
clidinium and psycholeptics
A03CA02 [21600204]
1.5e+00
2.3e+00
—
—
—
1.7e+00
1.7e+00
cases:2.38%
controls:0.56%
cases:2.18%
controls:0.22%
—
—
—
—
—
—
cases:1.03%
controls:0.19%
cases:3.21%
controls:0.59%
12
28
493
5001
11
11
494
5018
—
—
—
5
9
481
4839
13
24
392
4043
Medical doctor
Z2221 [2001311556]
9.6e-01
1.5e+00
1.5e+00
—
—
1.6e+00
1.4e+00
cases:11.68%
controls:4.83%
cases:5.35%
controls:1.29%
cases:0.99%
controls:0.22%
—
—
—
—
cases:4.94%
controls:0.99%
cases:8.89%
controls:2.31%
59
243
446
4786
27
65
478
4964
5
11
500
5018
—
—
24
48
462
4800
36
94
369
3973
Ileoscopy through colon
UJF30 [2001305028]
4.6e-01
1.9e+00
—
1.0e+50
—
2.2e+00
1.3e+00
cases:1.78%
controls:1.13%
cases:2.38%
controls:0.36%
—
—
cases:0.99%
controls:0.00%
—
—
cases:3.50%
controls:0.39%
cases:4.20%
controls:1.16%
9
57
496
4972
12
18
493
5011
—
5
0
500
5029
—
17
19
469
4829
17
47
388
4020
Prothrombin time (PT) actual/Normal
5894-1 [3033658]
6.6e-01
9.5e-01
1.7e+00
—
1.0e+00
1.1e+00
9.6e-01
cases:9.50%
controls:5.15%
cases:5.94%
controls:2.39%
cases:1.78%
controls:0.32%
—
—
cases:0.99%
controls:0.36%
cases:5.76%
controls:1.94%
cases:14.57%
controls:6.12%
48
259
457
4770
30
120
475
4909
9
16
496
5013
—
5
18
498
4997
28
94
458
4754
59
249
346
3818
Bacteria [Presence] in Urine
87829-8 [36304419]
6.2e-01
7.9e-01
1.9e+00
—
—
1.2e+00
9.2e-01
cases:9.31%
controls:5.23%
cases:4.75%
controls:2.21%
cases:1.78%
controls:0.28%
—
—
—
—
cases:6.79%
controls:2.15%
cases:15.80%
controls:6.96%
47
263
458
4766
24
111
481
4918
9
14
496
5015
—
—
33
104
453
4744
64
283
341
3784
Elastase.pancreatic [Mass/mass] in Stool
25907-7 [3000570]
7.8e-01
3.6e+00
—
—
—
—
1.8e+00
cases:0.99%
controls:0.46%
cases:3.37%
controls:0.10%
—
—
—
—
—
—
—
—
cases:2.96%
controls:0.49%
5
23
500
5006
17
5
488
5024
—
—
—
—
12
20
393
4047
Supplier / Service Provider
OMOP5117446 [33004]
-4.1e-01
-3.8e-01
4.8e-01
—
—
2.9e+00
2.9e+00
cases:20.99%
controls:28.61%
cases:7.33%
controls:10.34%
cases:1.78%
controls:1.11%
—
—
—
—
cases:8.85%
controls:0.54%
cases:17.78%
controls:1.20%
106
1439
399
3590
37
520
468
4509
9
56
496
4973
—
—
43
26
443
4822
72
49
333
4018
pH of Serum or Plasma
2753-2 [3018418]
5.5e-01
8.7e-01
1.5e+00
—
1.4e+00
8.8e-01
6.8e-01
cases:8.91%
controls:5.35%
cases:6.73%
controls:2.92%
cases:1.98%
controls:0.46%
—
—
cases:1.99%
controls:0.50%
cases:7.00%
controls:3.01%
cases:13.58%
controls:7.40%
45
269
460
4760
34
147
471
4882
10
23
495
5006
—
10
25
493
4990
34
146
452
4702
55
301
350
3766
Emergency Room Visit
ER [9203]
3.9e-01
6.1e-01
2.1e+00
—
9.6e-01
7.0e-01
5.4e-01
cases:41.78%
controls:32.73%
cases:17.03%
controls:10.04%
cases:6.93%
controls:0.91%
—
—
cases:3.18%
controls:1.24%
cases:15.43%
controls:8.29%
cases:34.32%
controls:23.31%
211
1646
294
3383
86
505
419
4524
35
46
470
4983
—
16
62
487
4953
75
402
411
4446
139
948
266
3119
saccharomyces boulardii; oral
A07FA02 [21600670]
1.4e+00
2.1e+00
—
—
—
1.8e+00
7.4e-01
cases:2.97%
controls:0.74%
cases:2.38%
controls:0.30%
—
—
—
—
—
—
cases:1.44%
controls:0.25%
cases:1.73%
controls:0.84%
15
37
490
4992
12
15
493
5014
—
—
—
7
12
479
4836
7
34
398
4033
Casts [#/volume] in Urine by Automated count
51483-6 [3030467]
5.6e-01
8.0e-01
1.7e+00
—
—
1.2e+00
9.1e-01
cases:9.31%
controls:5.53%
cases:4.95%
controls:2.29%
cases:1.78%
controls:0.32%
—
—
—
—
cases:7.00%
controls:2.23%
cases:15.80%
controls:7.01%
47
278
458
4751
25
115
480
4914
9
16
496
5013
—
—
34
108
452
4740
64
285
341
3782
Leukocytes [#/volume] in Urine
30405-5 [3018095]
5.4e-01
9.9e-01
1.5e+00
1.0e+50
—
1.1e+00
9.2e-01
cases:11.29%
controls:6.90%
cases:8.12%
controls:3.18%
cases:2.38%
controls:0.54%
cases:0.99%
controls:0.00%
—
—
cases:10.29%
controls:3.57%
cases:23.21%
controls:10.72%
57
347
448
4682
41
160
464
4869
12
27
493
5002
5
0
500
5029
—
50
173
436
4675
94
436
311
3631
CBC panel - Blood by Automated count
58410-2 [40761511]
1.3e-01
2.3e-01
1.1e+00
3.1e+00
8.2e-01
2.1e-01
1.9e-01
cases:41.58%
controls:38.44%
cases:29.31%
controls:24.78%
cases:11.29%
controls:3.92%
cases:4.75%
controls:0.22%
cases:8.35%
controls:3.85%
cases:27.78%
controls:23.82%
cases:51.85%
controls:47.14%
210
1933
295
3096
148
1246
357
3783
57
197
448
4832
24
11
481
5018
42
193
461
4822
135
1155
351
3693
210
1917
195
2150
Shigella sp [Presence] in Stool by Culture
82300-5 [42529406]
1.5e+00
3.6e+00
1.0e+50
—
—
2.3e+00
1.6e+00
cases:3.76%
controls:0.86%
cases:5.35%
controls:0.16%
cases:1.78%
controls:0.00%
—
—
—
—
cases:1.03%
controls:0.10%
cases:1.73%
controls:0.37%
19
43
486
4986
27
8
478
5021
9
0
496
5029
—
—
5
5
481
4843
7
15
398
4052
Yersinia sp identified in Stool by Organism specific culture
28549-4 [3014765]
1.5e+00
3.6e+00
1.0e+50
—
—
2.3e+00
1.6e+00
cases:3.76%
controls:0.86%
cases:5.35%
controls:0.16%
cases:1.78%
controls:0.00%
—
—
—
—
cases:1.03%
controls:0.10%
cases:1.73%
controls:0.37%
19
43
486
4986
27
8
478
5021
9
0
496
5029
—
—
5
5
481
4843
7
15
398
4052
Tissue transglutaminase IgG Ab [Units/volume] in Serum
32998-7 [3046870]
9.5e-01
3.0e+00
—
—
—
2.0e+00
6.7e-01
cases:1.58%
controls:0.62%
cases:4.55%
controls:0.24%
—
—
—
—
—
—
cases:1.85%
controls:0.25%
cases:3.21%
controls:1.67%
8
31
497
4998
23
12
482
5017
—
—
—
9
12
477
4836
13
68
392
3999
Examination and observation for other specified reasons
Z04.8 [45552063]
5.3e-01
1.9e+00
—
—
2.3e+00
1.9e+00
1.2e+00
cases:2.97%
controls:1.77%
cases:2.57%
controls:0.38%
—
—
—
—
cases:0.99%
controls:0.10%
cases:3.70%
controls:0.58%
cases:5.93%
controls:1.89%
15
89
490
4940
13
19
492
5010
—
—
5
5
498
5010
18
28
468
4820
24
77
381
3990
Campylobacter sp identified in Tissue by Organism specific culture
20740-7 [3006418]
1.5e+00
3.4e+00
1.0e+50
—
—
2.3e+00
1.5e+00
cases:3.76%
controls:0.86%
cases:5.35%
controls:0.18%
cases:1.98%
controls:0.00%
—
—
—
—
cases:1.03%
controls:0.10%
cases:1.73%
controls:0.39%
19
43
486
4986
27
9
478
5020
10
0
495
5029
—
—
5
5
481
4843
7
16
398
4051
FEV1/FVC --post bronchodilation
69970-2 [42868459]
7.7e-01
1.5e+00
—
—
—
1.6e+00
1.7e+00
cases:3.76%
controls:1.77%
cases:1.98%
controls:0.44%
—
—
—
—
—
—
cases:2.47%
controls:0.50%
cases:5.43%
controls:1.06%
19
89
486
4940
10
22
495
5007
—
—
—
12
24
474
4824
22
43
383
4024
FEV1 percent change
69983-5 [42868472]
7.7e-01
1.5e+00
—
—
—
1.6e+00
1.7e+00
cases:3.76%
controls:1.77%
cases:1.98%
controls:0.44%
—
—
—
—
—
—
cases:2.47%
controls:0.50%
cases:5.43%
controls:1.06%
19
89
486
4940
10
22
495
5007
—
—
—
12
24
474
4824
22
43
383
4024
Forced vital capacity [Volume] Respiratory system --post bronchodilation
19875-4 [3001668]
7.7e-01
1.5e+00
—
—
—
1.6e+00
1.7e+00
cases:3.76%
controls:1.77%
cases:1.98%
controls:0.44%
—
—
—
—
—
—
cases:2.47%
controls:0.50%
cases:5.43%
controls:1.06%
19
89
486
4940
10
22
495
5007
—
—
—
12
24
474
4824
22
43
383
4024
FEV1 --post bronchodilation
20155-8 [3023550]
7.7e-01
1.5e+00
—
—
—
1.6e+00
1.7e+00
cases:3.76%
controls:1.77%
cases:1.98%
controls:0.44%
—
—
—
—
—
—
cases:2.47%
controls:0.50%
cases:5.43%
controls:1.06%
19
89
486
4940
10
22
495
5007
—
—
—
12
24
474
4824
22
43
383
4024
FVC percent change Respiratory system
69982-7 [42868471]
7.7e-01
1.5e+00
—
—
—
1.6e+00
1.7e+00
cases:3.76%
controls:1.77%
cases:1.98%
controls:0.44%
—
—
—
—
—
—
cases:2.47%
controls:0.50%
cases:5.43%
controls:1.06%
19
89
486
4940
10
22
495
5007
—
—
—
12
24
474
4824
22
43
383
4024
colestyramine; oral
C10AC01 [21601876]
—
2.6e+00
—
—
—
—
2.2e+00
—
—
cases:1.39%
controls:0.10%
—
—
—
—
—
—
—
—
cases:1.48%
controls:0.17%
—
7
5
498
5024
—
—
—
—
6
7
399
4060
Calcium.ionized [Moles/volume] in Serum or Plasma
1995-0 [3021347]
3.4e-01
6.6e-01
1.7e+00
—
1.3e+00
6.4e-01
4.8e-01
cases:12.48%
controls:9.21%
cases:8.71%
controls:4.69%
cases:2.97%
controls:0.58%
—
—
cases:2.78%
controls:0.74%
cases:8.64%
controls:4.74%
cases:17.04%
controls:11.26%
63
463
442
4566
44
236
461
4793
15
29
490
5000
—
14
37
489
4978
42
230
444
4618
69
458
336
3609
Holo-transcobalamin II [Moles/volume] in Serum
72160-5 [43054903]
6.2e-01
9.1e-01
1.6e+00
—
1.0e+00
7.8e-01
7.8e-01
cases:13.47%
controls:7.74%
cases:9.11%
controls:3.88%
cases:1.98%
controls:0.40%
—
—
cases:0.99%
controls:0.36%
cases:9.26%
controls:4.46%
cases:24.20%
controls:12.71%
68
389
437
4640
46
195
459
4834
10
20
495
5009
—
5
18
498
4997
45
216
441
4632
98
517
307
3550
Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
19072-8 [3016431]
2.9e-01
6.8e-01
1.9e+00
—
1.5e+00
6.2e-01
4.0e-01
cases:13.07%
controls:10.14%
cases:10.10%
controls:5.37%
cases:4.16%
controls:0.68%
—
—
cases:3.58%
controls:0.80%
cases:9.67%
controls:5.47%
cases:19.26%
controls:13.77%
66
510
439
4519
51
270
454
4759
21
34
484
4995
—
18
40
485
4975
47
265
439
4583
78
560
327
3507
budesonide; oral, sublingual
A07EA06 [21600658]
1.2e+00
2.2e+00
—
—
—
2.5e+00
1.2e+00
cases:1.39%
controls:0.44%
cases:1.39%
controls:0.16%
—
—
—
—
—
—
cases:2.47%
controls:0.21%
cases:2.22%
controls:0.66%
7
22
498
5007
7
8
498
5021
—
—
—
12
10
474
4838
9
27
396
4040
Tissue Pathology biopsy report
66121-5 [40768804]
6.3e-01
6.5e-01
—
—
2.2e+00
1.2e+00
6.5e-01
cases:16.24%
controls:9.35%
cases:6.53%
controls:3.52%
—
—
—
—
cases:1.39%
controls:0.16%
cases:8.85%
controls:2.85%
cases:16.54%
controls:9.37%
82
470
423
4559
33
177
472
4852
—
—
7
8
496
5007
43
138
443
4710
67
381
338
3686
Other specified counselling
Z71.8 [45581061]
4.1e-01
9.8e-01
1.6e+00
—
8.7e-01
1.1e+00
8.5e-01
cases:7.52%
controls:5.13%
cases:6.53%
controls:2.57%
cases:1.78%
controls:0.36%
—
—
cases:0.99%
controls:0.42%
cases:7.41%
controls:2.62%
cases:20.00%
controls:9.69%
38
258
467
4771
33
129
472
4900
9
18
496
5011
—
5
21
498
4994
36
127
450
4721
81
394
324
3673
Ferritin [Mass/volume] in Serum or Plasma
2276-4 [3001122]
4.9e-01
1.0e+00
1.5e+00
—
4.1e-01
7.2e-01
6.5e-01
cases:16.63%
controls:10.86%
cases:16.83%
controls:6.80%
cases:3.37%
controls:0.74%
—
—
cases:1.59%
controls:1.06%
cases:13.58%
controls:7.10%
cases:30.62%
controls:18.66%
84
546
421
4483
85
342
420
4687
17
37
488
4992
—
8
53
495
4962
66
344
420
4504
124
759
281
3308
proguanil and atovaquone
P01BB51 [21604895]
1.5e+00
2.3e+00
—
—
—
—
2.1e+00
cases:1.39%
controls:0.32%
cases:1.19%
controls:0.12%
—
—
—
—
—
—
—
—
cases:1.98%
controls:0.25%
7
16
498
5013
6
6
499
5023
—
—
—
—
8
10
397
4057
Epithelial cells [#/volume] in Urine
30383-4 [3000850]
5.4e-01
9.0e-02
2.3e+00
—
—
1.3e+00
7.2e-01
cases:6.93%
controls:4.18%
cases:1.78%
controls:1.63%
cases:1.19%
controls:0.12%
—
—
—
—
cases:4.53%
controls:1.26%
cases:8.40%
controls:4.28%
35
210
470
4819
9
82
496
4947
6
6
499
5023
—
—
22
61
464
4787
34
174
371
3893
Bacteria [#/volume] in Urine by Automated count
51480-2 [3031040]
4.1e-01
6.0e-01
1.8e+00
1.0e+50
6.2e-01
8.1e-01
6.5e-01
cases:24.16%
controls:17.48%
cases:13.07%
controls:7.66%
cases:4.95%
controls:0.87%
cases:0.99%
controls:0.00%
cases:2.39%
controls:1.30%
cases:16.26%
controls:7.98%
cases:33.33%
controls:20.65%
122
879
383
4150
66
385
439
4644
25
44
480
4985
5
0
500
5029
12
65
491
4950
79
387
407
4461
135
840
270
3227
Urinalysis macro (dipstick) panel - Urine
24357-6 [3037467]
4.1e-01
7.3e-01
1.6e+00
1.0e+50
8.0e-01
7.3e-01
7.1e-01
cases:26.53%
controls:19.33%
cases:16.83%
controls:8.89%
cases:4.36%
controls:0.95%
cases:1.19%
controls:0.00%
cases:2.58%
controls:1.18%
cases:17.08%
controls:9.01%
cases:37.53%
controls:22.84%
134
972
371
4057
85
447
420
4582
22
48
483
4981
6
0
499
5029
13
59
490
4956
83
437
403
4411
152
929
253
3138
Telehealth
OMOP5556618 [722455]
4.5e-01
9.1e-01
1.5e+00
—
5.4e-01
7.3e-01
4.4e-01
cases:39.80%
controls:29.75%
cases:22.77%
controls:10.60%
cases:7.33%
controls:1.79%
—
—
cases:3.18%
controls:1.87%
cases:17.08%
controls:9.03%
cases:28.89%
controls:20.78%
201
1496
304
3533
115
533
390
4496
37
90
468
4939
—
16
94
487
4921
83
438
403
4410
117
845
288
3222
Irritable bowel syndrome
K58 [45572218]
7.3e-01
2.2e+00
—
—
—
—
1.8e+00
cases:0.99%
controls:0.48%
cases:1.19%
controls:0.14%
—
—
—
—
—
—
—
—
cases:1.98%
controls:0.32%
5
24
500
5005
6
7
499
5022
—
—
—
—
8
13
397
4054
Folate [Moles/volume] in Serum or Plasma
14732-2 [3021960]
2.7e-01
9.8e-01
2.3e+00
—
—
7.2e-01
7.0e-01
cases:3.37%
controls:2.59%
cases:3.96%
controls:1.53%
cases:1.19%
controls:0.12%
—
—
—
—
cases:4.73%
controls:2.35%
cases:13.09%
controls:6.96%
17
130
488
4899
20
77
485
4952
6
6
499
5023
—
—
23
114
463
4734
53
283
352
3784
Osmolality of Urine
2695-5 [3026782]
6.3e-01
3.9e-01
2.3e+00
—
—
9.9e-01
5.8e-01
cases:8.12%
controls:4.47%
cases:2.18%
controls:1.49%
cases:1.58%
controls:0.16%
—
—
—
—
cases:3.70%
controls:1.40%
cases:6.67%
controls:3.86%
41
225
464
4804
11
75
494
4954
8
8
497
5021
—
—
18
68
468
4780
27
157
378
3910
Inpatient Hospital
21 [8717]
2.3e-01
2.4e-01
1.5e+00
—
1.4e+00
6.4e-01
4.5e-01
cases:31.49%
controls:26.80%
cases:9.50%
controls:7.62%
cases:3.56%
controls:0.84%
—
—
cases:3.78%
controls:1.00%
cases:12.14%
controls:6.81%
cases:25.68%
controls:18.05%
159
1348
346
3681
48
383
457
4646
18
42
487
4987
—
19
50
484
4965
59
330
427
4518
104
734
301
3333
General Practice
1 [38004446]
5.6e-01
5.3e-01
1.8e+00
—
1.1e+00
8.3e-01
6.4e-01
cases:18.02%
controls:11.18%
cases:6.93%
controls:4.20%
cases:2.77%
controls:0.46%
—
—
cases:1.59%
controls:0.54%
cases:9.47%
controls:4.35%
cases:18.52%
controls:10.70%
91
562
414
4467
35
211
470
4818
14
23
491
5006
—
8
27
495
4988
46
211
440
4637
75
435
330
3632
Scheduled procedure
ZXD10 [2001311387]
7.6e-01
1.3e-02
—
—
—
1.5e+00
1.5e+00
cases:11.68%
controls:5.85%
cases:1.19%
controls:1.17%
—
—
—
—
—
—
cases:3.91%
controls:0.87%
cases:9.38%
controls:2.19%
59
294
446
4735
6
59
499
4970
—
—
—
19
42
467
4806
38
89
367
3978
Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1920-8 [3013721]
1.4e-01
7.2e-01
1.5e+00
—
1.5e+00
5.6e-01
4.4e-01
cases:8.71%
controls:7.66%
cases:6.53%
controls:3.28%
cases:1.98%
controls:0.44%
—
—
cases:1.99%
controls:0.44%
cases:5.97%
controls:3.49%
cases:14.81%
controls:10.06%
44
385
461
4644
33
165
472
4864
10
22
495
5007
—
10
22
493
4993
29
169
457
4679
60
409
345
3658
Hemoglobin.gastrointestinal [Presence] in Stool
2335-8 [3016251]
1.2e+00
2.5e+00
—
—
—
—
9.6e-01
cases:2.97%
controls:0.93%
cases:2.97%
controls:0.24%
—
—
—
—
—
—
—
—
cases:2.72%
controls:1.06%
15
47
490
4982
15
12
490
5017
—
—
—
—
11
43
394
4024
Erythrocytes [#/volume] in Urine
30391-7 [3002582]
5.4e-01
6.8e-01
1.7e+00
—
—
1.1e+00
8.1e-01
cases:9.90%
controls:6.04%
cases:5.15%
controls:2.66%
cases:2.18%
controls:0.40%
—
—
—
—
cases:8.02%
controls:2.72%
cases:17.28%
controls:8.53%
50
304
455
4725
26
134
479
4895
11
20
494
5009
—
—
39
132
447
4716
70
347
335
3720
Thyrotropin [Units/volume] in Serum or Plasma
3016-3 [3009201]
3.5e-01
6.5e-01
1.7e+00
—
6.5e-01
4.4e-01
4.5e-01
cases:39.21%
controls:31.20%
cases:30.89%
controls:18.95%
cases:12.67%
controls:2.51%
—
—
cases:4.97%
controls:2.65%
cases:26.13%
controls:18.50%
cases:53.58%
controls:42.32%
198
1569
307
3460
156
953
349
4076
64
126
441
4903
—
25
133
478
4882
127
897
359
3951
217
1721
188
2346
Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
30248-9 [3015399]
5.5e-01
1.1e+00
1.6e+00
—
—
7.0e-01
8.3e-01
cases:8.32%
controls:4.99%
cases:7.72%
controls:2.59%
cases:1.58%
controls:0.32%
—
—
—
—
cases:5.35%
controls:2.72%
cases:14.07%
controls:6.64%
42
251
463
4778
39
130
466
4899
8
16
497
5013
—
—
26
132
460
4716
57
270
348
3797
Pharmacy visit
OMOP4822462 [581458]
1.2e-01
7.4e-01
5.1e-01
1.8e+00
5.0e-01
4.7e-01
5.0e-01
cases:93.66%
controls:92.94%
cases:91.49%
controls:83.62%
cases:54.26%
controls:41.64%
cases:10.89%
controls:1.95%
cases:56.26%
controls:43.93%
cases:89.30%
controls:83.95%
cases:96.79%
controls:94.81%
473
4674
32
355
462
4205
43
824
274
2094
231
2935
55
98
450
4931
283
2203
220
2812
434
4070
52
778
392
3856
13
211
Short blood count panel - Blood
55429-5 [40758558]
6.2e-01
1.6e-01
2.3e+00
—
9.5e-01
6.6e-01
5.7e-01
cases:11.68%
controls:6.64%
cases:4.55%
controls:3.92%
cases:8.12%
controls:0.87%
—
—
cases:2.78%
controls:1.10%
cases:6.58%
controls:3.51%
cases:12.10%
controls:7.23%
59
334
446
4695
23
197
482
4832
41
44
464
4985
—
14
55
489
4960
32
170
454
4678
49
294
356
3773
Urinalysis microscopic panel [#/volume] - Urine by Automated count
50554-5 [3029287]
3.7e-01
6.2e-01
1.7e+00
—
8.0e-01
1.0e+00
7.7e-01
cases:10.50%
controls:7.52%
cases:5.54%
controls:3.06%
cases:2.38%
controls:0.46%
—
—
cases:1.19%
controls:0.54%
cases:8.64%
controls:3.24%
cases:18.27%
controls:9.37%
53
378
452
4651
28
154
477
4875
12
23
493
5006
—
6
27
497
4988
42
157
444
4691
74
381
331
3686
Epithelial cells.non-squamous [#/volume] in Urine by Automated count
51485-1 [3030306]
4.6e-01
1.3e+00
—
—
—
1.3e+00
8.8e-01
cases:3.96%
controls:2.55%
cases:3.96%
controls:1.11%
—
—
—
—
—
—
cases:4.73%
controls:1.38%
cases:10.62%
controls:4.70%
20
128
485
4901
20
56
485
4973
—
—
—
23
67
463
4781
43
191
362
3876
hydroxyzine; oral, parenteral
N05BB01 [21604590]
9.8e-01
1.2e+00
-1.0e+50
—
—
1.2e+00
7.7e-01
cases:6.14%
controls:2.39%
cases:2.77%
controls:0.82%
cases:0.00%
controls:0.20%
—
—
—
—
cases:3.09%
controls:0.95%
cases:5.43%
controls:2.58%
31
120
474
4909
14
41
491
4988
0
10
505
5019
—
—
15
46
471
4802
22
105
383
3962
Physiotherapist
Z3226 [2001311560]
6.1e-01
9.2e-01
—
—
—
1.7e+00
1.7e+00
cases:4.36%
controls:2.41%
cases:1.58%
controls:0.64%
—
—
—
—
—
—
cases:1.85%
controls:0.35%
cases:3.70%
controls:0.69%
22
121
483
4908
8
32
497
4997
—
—
—
9
17
477
4831
15
28
390
4039
Pain localized to other parts of lower abdomen
R10.3 [45534426]
3.8e-01
1.2e+00
—
—
—
1.2e+00
9.9e-01
cases:6.14%
controls:4.28%
cases:4.75%
controls:1.51%
—
—
—
—
—
—
cases:4.53%
controls:1.44%
cases:11.85%
controls:4.75%
31
215
474
4814
24
76
481
4953
—
—
—
22
70
464
4778
48
193
357
3874
Left sided colitis
K51.5 [45533604]
1.5e+00
1.6e+00
2.1e+00
—
—
1.7e+00
1.4e+00
cases:1.98%
controls:0.44%
cases:1.58%
controls:0.34%
cases:0.99%
controls:0.12%
—
—
—
—
cases:1.85%
controls:0.33%
cases:1.73%
controls:0.44%
10
22
495
5007
8
17
497
5012
5
6
500
5023
—
—
9
16
477
4832
7
18
398
4049
Blepharitis
H01.0 [45533180]
1.9e+00
—
—
—
—
—
1.4e+00
cases:2.38%
controls:0.38%
—
—
—
—
—
—
—
—
—
—
cases:3.70%
controls:0.98%
12
19
493
5010
—
—
—
—
—
15
40
390
4027
One hour or less
ZXE00 [2001311394]
7.0e-01
3.5e-02
—
—
-1.0e+50
1.2e+00
1.3e+00
cases:11.68%
controls:6.16%
cases:1.58%
controls:1.53%
—
—
—
—
cases:0.00%
controls:0.10%
cases:3.50%
controls:1.11%
cases:10.86%
controls:3.17%
59
310
446
4719
8
77
497
4952
—
—
0
5
503
5010
17
54
469
4794
44
129
361
3938
Amylase [Enzymatic activity/volume] in Serum or Plasma
1798-8 [3016771]
1.9e-01
8.8e-01
2.3e+00
1.0e+50
1.3e+00
6.1e-01
2.9e-01
cases:6.93%
controls:5.79%
cases:6.14%
controls:2.64%
cases:3.96%
controls:0.42%
cases:1.39%
controls:0.00%
cases:1.19%
controls:0.34%
cases:4.32%
controls:2.39%
cases:10.37%
controls:7.97%
35
291
470
4738
31
133
474
4896
20
21
485
5008
7
0
498
5029
6
17
497
4998
21
116
465
4732
42
324
363
3743
esomeprazole; oral, parenteral
A02BC05 [21600100]
7.0e-01
9.3e-01
3.3e-01
—
5.9e-01
6.8e-01
8.5e-01
cases:14.65%
controls:7.85%
cases:9.31%
controls:3.88%
cases:0.99%
controls:0.72%
—
—
cases:1.39%
controls:0.78%
cases:7.00%
controls:3.67%
cases:15.80%
controls:7.45%
74
395
431
4634
47
195
458
4834
5
36
500
4993
—
7
39
496
4976
34
178
452
4670
64
303
341
3764
Endomysium IgA Ab [Titer] in Serum
10863-9 [3020961]
7.5e-01
2.0e+00
—
—
—
1.4e+00
1.1e+00
cases:2.77%
controls:1.33%
cases:3.56%
controls:0.48%
—
—
—
—
—
—
cases:1.65%
controls:0.39%
cases:3.70%
controls:1.25%
14
67
491
4962
18
24
487
5005
—
—
—
8
19
478
4829
15
51
390
4016
ranitidine bismuth citrate; oral
A02BA07 [21600088]
6.5e-01
1.6e+00
—
—
—
1.3e+00
1.5e+00
cases:2.18%
controls:1.15%
cases:1.78%
controls:0.36%
—
—
—
—
—
—
cases:1.23%
controls:0.33%
cases:3.21%
controls:0.71%
11
58
494
4971
9
18
496
5011
—
—
—
6
16
480
4832
13
29
392
4038
ranitidine; oral, parenteral
A02BA02 [21600083]
6.5e-01
1.6e+00
—
—
—
1.3e+00
1.5e+00
cases:2.18%
controls:1.15%
cases:1.78%
controls:0.36%
—
—
—
—
—
—
cases:1.23%
controls:0.33%
cases:3.21%
controls:0.71%
11
58
494
4971
9
18
496
5011
—
—
—
6
16
480
4832
13
29
392
4038
Epithelial cells.squamous [#/volume] in Urine by Automated count
51486-9 [3029879]
4.3e-01
1.3e+00
1.3e+00
—
—
1.1e+00
8.2e-01
cases:3.96%
controls:2.62%
cases:3.96%
controls:1.15%
cases:0.99%
controls:0.28%
—
—
—
—
cases:3.91%
controls:1.40%
cases:9.88%
controls:4.60%
20
132
485
4897
20
58
485
4971
5
14
500
5015
—
—
19
68
467
4780
40
187
365
3880
zopiclone; oral
N05CF01 [21604654]
6.3e-01
3.6e-01
5.1e-01
—
1.1e+00
7.0e-01
6.6e-01
cases:10.50%
controls:5.87%
cases:4.95%
controls:3.50%
cases:1.19%
controls:0.72%
—
—
cases:2.98%
controls:0.98%
cases:7.00%
controls:3.59%
cases:10.37%
controls:5.66%
53
295
452
4734
25
176
480
4853
6
36
499
4993
—
15
49
488
4966
34
174
452
4674
42
230
363
3837
Malaise and fatigue
R53 [45553741]
6.0e-01
1.3e+00
—
—
—
1.1e+00
7.7e-01
cases:5.35%
controls:3.00%
cases:4.16%
controls:1.21%
—
—
—
—
—
—
cases:4.53%
controls:1.59%
cases:10.12%
controls:4.94%
27
151
478
4878
21
61
484
4968
—
—
—
22
77
464
4771
41
201
364
3866
FEV1
20150-9 [3024653]
6.3e-01
1.3e+00
—
—
—
1.5e+00
1.5e+00
cases:3.76%
controls:2.05%
cases:1.98%
controls:0.56%
—
—
—
—
—
—
cases:2.47%
controls:0.54%
cases:5.43%
controls:1.20%
19
103
486
4926
10
28
495
5001
—
—
—
12
26
474
4822
22
49
383
4018
FEV1/FVC
19926-5 [3011505]
6.3e-01
1.3e+00
—
—
—
1.5e+00
1.5e+00
cases:3.76%
controls:2.05%
cases:1.98%
controls:0.56%
—
—
—
—
—
—
cases:2.47%
controls:0.54%
cases:5.43%
controls:1.20%
19
103
486
4926
10
28
495
5001
—
—
—
12
26
474
4822
22
49
383
4018
Forced vital capacity [Volume] Respiratory system
19870-5 [3020158]
6.3e-01
1.3e+00
—
—
—
1.5e+00
1.5e+00
cases:3.76%
controls:2.05%
cases:1.98%
controls:0.56%
—
—
—
—
—
—
cases:2.47%
controls:0.54%
cases:5.43%
controls:1.20%
19
103
486
4926
10
28
495
5001
—
—
—
12
26
474
4822
22
49
383
4018
Glucose [Moles/volume] in Serum or Plasma
14749-6 [3013826]
-1.2e-01
-4.4e-02
1.7e+00
—
1.4e+00
1.1e-01
3.5e-01
cases:11.68%
controls:12.93%
cases:5.74%
controls:5.99%
cases:3.56%
controls:0.68%
—
—
cases:2.39%
controls:0.60%
cases:6.17%
controls:5.57%
cases:21.73%
controls:16.42%
59
650
446
4379
29
301
476
4728
18
34
487
4995
—
12
30
491
4985
30
270
456
4578
88
668
317
3399
mesalazine; oral, rectal
A07EC02 [21600664]
6.6e-01
9.5e-01
1.9e+00
—
1.1e+00
1.1e+00
7.5e-01
cases:2.18%
controls:1.13%
cases:2.57%
controls:1.01%
cases:1.78%
controls:0.26%
—
—
cases:1.19%
controls:0.40%
cases:2.88%
controls:0.95%
cases:2.47%
controls:1.18%
11
57
494
4972
13
51
492
4978
9
13
496
5016
—
6
20
497
4995
14
46
472
4802
10
48
395
4019
Physiotherapy
R4110 [2001310233]
7.5e-01
5.2e-01
—
—
—
1.2e+00
1.1e+00
cases:9.31%
controls:4.61%
cases:2.77%
controls:1.67%
—
—
—
—
—
—
cases:4.32%
controls:1.38%
cases:10.62%
controls:3.76%
47
232
458
4797
14
84
491
4945
—
—
—
21
67
465
4781
43
153
362
3914
Immunohistochemistry procedure
117617002 [4035726]
7.5e-01
6.7e-01
—
—
—
1.8e+00
1.2e+00
cases:2.97%
controls:1.43%
cases:1.39%
controls:0.72%
—
—
—
—
—
—
cases:1.85%
controls:0.31%
cases:3.70%
controls:1.13%
15
72
490
4957
7
36
498
4993
—
—
—
9
15
477
4833
15
46
390
4021
Noninfective gastroenteritis and colitis, unspecified
K52.9 [45572215]
1.3e+00
3.0e+00
1.0e+50
1.0e+50
—
—
1.0e+00
cases:0.99%
controls:0.26%
cases:1.98%
controls:0.10%
cases:1.58%
controls:0.00%
cases:0.99%
controls:0.00%
—
—
—
—
cases:1.23%
controls:0.44%
5
13
500
5016
10
5
495
5024
8
0
497
5029
5
0
500
5029
—
—
5
18
400
4049
Change in bowel habit
R19.4 [45573017]
—
3.0e+00
—
—
—
—
—
—
—
cases:1.98%
controls:0.10%
—
—
—
—
—
—
—
—
—
—
—
10
5
495
5024
—
—
—
—
—
Borrelia burgdorferi IgG Ab [Units/volume] in Serum
7817-0 [3016888]
6.4e-01
5.8e-01
—
—
—
1.9e+00
1.1e+00
cases:2.38%
controls:1.27%
cases:0.99%
controls:0.56%
—
—
—
—
—
—
cases:2.26%
controls:0.35%
cases:4.20%
controls:1.40%
12
64
493
4965
5
28
500
5001
—
—
—
11
17
475
4831
17
57
388
4010
Cardiac arrhythmia NOS
K80 [2002000607]
7.0e-01
—
—
—
—
1.8e+00
1.2e+00
cases:1.98%
controls:0.99%
—
—
—
—
—
—
—
—
cases:1.44%
controls:0.25%
cases:3.70%
controls:1.11%
10
50
495
4979
—
—
—
—
7
12
479
4836
15
45
390
4022
Iron [Moles/volume] in Serum or Plasma
14798-3 [3022948]
3.4e-01
5.8e-01
2.1e+00
—
—
7.5e-01
8.7e-01
cases:3.96%
controls:2.84%
cases:2.77%
controls:1.57%
cases:1.58%
controls:0.20%
—
—
—
—
cases:3.29%
controls:1.59%
cases:8.40%
controls:3.69%
20
143
485
4886
14
79
491
4950
8
10
497
5019
—
—
16
77
470
4771
34
150
371
3917
fluconazole; oral, parenteral
J02AC01 [21603080]
3.0e-01
8.8e-01
2.0e+00
—
—
7.5e-01
5.2e-01
cases:9.50%
controls:7.22%
cases:4.75%
controls:2.03%
cases:1.39%
controls:0.20%
—
—
—
—
cases:4.12%
controls:1.98%
cases:8.89%
controls:5.51%
48
363
457
4666
24
102
481
4927
7
10
498
5019
—
—
20
96
466
4752
36
224
369
3843
Venereal disease screening
171128005 [4064905]
1.2e+00
1.8e+00
—
—
—
1.6e+00
1.6e+00
cases:2.57%
controls:0.82%
cases:1.19%
controls:0.20%
—
—
—
—
—
—
cases:1.03%
controls:0.21%
cases:2.22%
controls:0.44%
13
41
492
4988
6
10
499
5019
—
—
—
5
10
481
4838
9
18
396
4049
Other specified noninfective gastroenteritis and colitis
K52.88 [2000502923]
—
—
—
—
—
2.8e+00
1.7e+00
—
—
—
—
—
—
—
—
—
—
cases:1.65%
controls:0.10%
cases:1.48%
controls:0.27%
—
—
—
—
—
8
5
478
4843
6
11
399
4056
Borrelia burgdorferi IgM Ab [Units/volume] in Serum
7818-8 [3008230]
6.6e-01
6.6e-01
—
—
—
1.7e+00
1.1e+00
cases:2.77%
controls:1.45%
cases:1.19%
controls:0.62%
—
—
—
—
—
—
cases:2.26%
controls:0.41%
cases:4.20%
controls:1.50%
14
73
491
4956
6
31
499
4998
—
—
—
11
20
475
4828
17
61
388
4006
Irritable bowel syndrome without diarrhoea
K58.9 [45538539]
—
—
—
—
—
2.8e+00
1.5e+00
—
—
—
—
—
—
—
—
—
—
cases:2.26%
controls:0.14%
cases:1.48%
controls:0.34%
—
—
—
—
—
11
7
475
4841
6
14
399
4053
Pain localized to upper abdomen
R10.1 [45568111]
7.3e-01
1.8e+00
—
—
—
4.8e-01
9.0e-01
cases:4.16%
controls:2.05%
cases:3.76%
controls:0.64%
—
—
—
—
—
—
cases:1.03%
controls:0.64%
cases:6.67%
controls:2.83%
21
103
484
4926
19
32
486
4997
—
—
—
5
31
481
4817
27
115
378
3952
omeprazole; oral, parenteral
A02BC01 [21600096]
7.0e-01
1.1e+00
—
—
—
6.1e-01
9.4e-01
cases:6.93%
controls:3.58%
cases:4.16%
controls:1.49%
—
—
—
—
—
—
cases:2.88%
controls:1.59%
cases:7.41%
controls:3.02%
35
180
470
4849
21
75
484
4954
—
—
—
14
77
472
4771
30
123
375
3944
Bacteria identified in Blood by Culture
600-7 [3023368]
2.3e-01
-6.1e-01
2.0e+00
1.0e+50
1.1e+00
6.0e-01
6.5e-01
cases:4.55%
controls:3.64%
cases:0.99%
controls:1.81%
cases:1.78%
controls:0.24%
cases:1.39%
controls:0.00%
cases:0.99%
controls:0.34%
cases:2.88%
controls:1.61%
cases:8.89%
controls:4.84%
23
183
482
4846
5
91
500
4938
9
12
496
5017
7
0
498
5029
5
17
498
4998
14
78
472
4770
36
197
369
3870
Calcium [Moles/volume] corrected for albumin in Serum or Plasma
29265-6 [3020059]
8.8e-01
9.5e-01
—
—
—
7.1e-01
8.3e-01
cases:6.14%
controls:2.64%
cases:3.37%
controls:1.33%
—
—
—
—
—
—
cases:2.88%
controls:1.44%
cases:9.63%
controls:4.43%
31
133
474
4896
17
67
488
4962
—
—
—
14
70
472
4778
39
180
366
3887
Protein [Presence] in Urine by Test strip
20454-5 [3014051]
4.8e-01
1.2e+00
1.2e+00
—
—
7.4e-01
7.0e-01
cases:7.52%
controls:4.77%
cases:7.33%
controls:2.29%
cases:1.19%
controls:0.38%
—
—
—
—
cases:6.17%
controls:3.05%
cases:18.27%
controls:9.98%
38
240
467
4789
37
115
468
4914
6
19
499
5010
—
—
30
148
456
4700
74
406
331
3661
ispaghula (psylla seeds); oral
A06AC01 [21600555]
5.9e-01
1.0e+00
7.8e-01
—
—
8.5e-01
7.7e-01
cases:6.14%
controls:3.50%
cases:5.15%
controls:1.95%
cases:0.99%
controls:0.46%
—
—
—
—
cases:5.14%
controls:2.27%
cases:8.89%
controls:4.30%
31
176
474
4853
26
98
479
4931
5
23
500
5006
—
—
25
110
461
4738
36
175
369
3892
Thyroxine (T4) free [Moles/volume] in Serum or Plasma
14920-3 [3008486]
4.0e-01
5.0e-01
8.4e-01
—
7.3e-01
4.7e-01
3.9e-01
cases:32.67%
controls:24.64%
cases:21.19%
controls:14.02%
cases:4.36%
controls:1.93%
—
—
cases:3.58%
controls:1.75%
cases:19.96%
controls:13.51%
cases:41.98%
controls:32.85%
165
1239
340
3790
107
705
398
4324
22
97
483
4932
—
18
88
485
4927
97
655
389
4193
170
1336
235
2731
Cutaneous abscess, furuncle and carbuncle of buttock
L02.3 [45548181]
—
—
—
—
—
—
2.5e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.48%
controls:0.12%
—
—
—
—
—
—
6
5
399
4062
ipratropium bromide; inhalant
R03BB01 [21603293]
2.5e+00
—
—
—
—
—
1.8e+00
cases:1.19%
controls:0.10%
—
—
—
—
—
—
—
—
—
—
cases:1.23%
controls:0.20%
6
5
499
5024
—
—
—
—
—
5
8
400
4059
Hemoglobin [Presence] in Urine by Test strip
5794-3 [3011397]
4.9e-02
1.0e+00
1.1e+00
—
—
7.7e-01
7.0e-01
cases:4.75%
controls:4.53%
cases:5.94%
controls:2.27%
cases:0.99%
controls:0.34%
—
—
—
—
cases:5.97%
controls:2.87%
cases:16.05%
controls:8.68%
24
228
481
4801
30
114
475
4915
5
17
500
5012
—
—
29
139
457
4709
65
353
340
3714
Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
14804-9 [3022250]
3.2e-01
7.4e-01
—
—
1.9e+00
1.3e+00
1.1e+00
cases:2.18%
controls:1.59%
cases:1.98%
controls:0.95%
—
—
—
—
cases:1.19%
controls:0.18%
cases:2.88%
controls:0.78%
cases:6.91%
controls:2.39%
11
80
494
4949
10
48
495
4981
—
—
6
9
497
5006
14
38
472
4810
28
97
377
3970
ciprofloxacin; oral, parenteral
J01MA02 [21603009]
7.0e-01
1.0e+00
—
—
—
8.8e-01
7.3e-01
cases:8.71%
controls:4.51%
cases:3.17%
controls:1.19%
—
—
—
—
—
—
cases:3.09%
controls:1.30%
cases:7.65%
controls:3.84%
44
227
461
4802
16
60
489
4969
—
—
—
15
63
471
4785
31
156
374
3911
estradiol; nasal, oral, parenteral, rectal, transdermal, vaginal
G03CA03 [21602517]
4.3e-01
5.9e-01
2.7e-01
—
8.6e-01
4.3e-01
5.3e-01
cases:18.81%
controls:13.10%
cases:15.05%
controls:8.95%
cases:3.17%
controls:2.43%
—
—
cases:5.57%
controls:2.43%
cases:14.40%
controls:9.84%
cases:24.44%
controls:16.03%
95
659
410
4370
76
450
429
4579
16
122
489
4907
—
28
122
475
4893
70
477
416
4371
99
652
306
3415
pivmecillinam; oral
J01CA08 [21602827]
3.6e-01
5.6e-01
1.8e+00
—
—
3.2e-01
5.6e-01
cases:11.88%
controls:8.63%
cases:5.35%
controls:3.12%
cases:1.58%
controls:0.26%
—
—
—
—
cases:4.12%
controls:3.01%
cases:15.06%
controls:9.22%
60
434
445
4595
27
157
478
4872
8
13
497
5016
—
—
20
146
466
4702
61
375
344
3692
budesonide; inhalant
R03BA02 [21603285]
7.4e-01
7.3e-01
5.7e-01
—
7.2e-01
8.8e-01
3.1e-01
cases:10.89%
controls:5.49%
cases:6.34%
controls:3.16%
cases:1.19%
controls:0.68%
—
—
cases:1.59%
controls:0.78%
cases:7.00%
controls:3.03%
cases:7.65%
controls:5.73%
55
276
450
4753
32
159
473
4870
6
34
499
4995
—
8
39
495
4976
34
147
452
4701
31
233
374
3834
Inpatient Visit
IP [9201]
1.8e-01
2.6e-01
1.8e+00
1.0e+50
1.2e+00
5.4e-01
5.6e-01
cases:6.34%
controls:5.37%
cases:3.76%
controls:2.92%
cases:1.39%
controls:0.24%
cases:2.97%
controls:0.00%
cases:1.39%
controls:0.42%
cases:5.14%
controls:3.05%
cases:13.09%
controls:7.94%
32
270
473
4759
19
147
486
4882
7
12
498
5017
15
0
490
5029
7
21
496
4994
25
148
461
4700
53
323
352
3744
Production of copy from X-ray picture
XX9AW [2001311036]
—
—
—
—
—
—
2.3e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.48%
controls:0.15%
—
—
—
—
—
—
6
6
399
4061
Diaphragmatic hernia without obstruction or gangrene
K44.9 [45533596]
7.6e-01
2.3e+00
—
—
—
1.4e+00
6.3e-01
cases:1.39%
controls:0.66%
cases:1.19%
controls:0.12%
—
—
—
—
—
—
cases:1.03%
controls:0.27%
cases:1.23%
controls:0.66%
7
33
498
4996
6
6
499
5023
—
—
—
5
13
481
4835
5
27
400
4040
Clinical & Laboratory Dermatological Immunology Physician
207NI0002X [38003841]
8.8e-01
7.5e-01
1.2e+00
—
—
5.8e-01
6.5e-01
cases:15.25%
controls:6.96%
cases:6.73%
controls:3.30%
cases:2.18%
controls:0.70%
—
—
—
—
cases:5.56%
controls:3.18%
cases:13.83%
controls:7.72%
77
350
428
4679
34
166
471
4863
11
35
494
4994
—
—
27
154
459
4694
56
314
349
3753
Other reason for encounter NEC
-69 [2002000140]
—
—
—
—
—
—
2.2e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.98%
controls:0.22%
—
—
—
—
—
—
8
9
397
4058
CT examination of arteria pulmonalis
FB1AD [2001302404]
-1.0e+50
—
—
—
—
—
2.2e+00
cases:0.00%
controls:0.12%
—
—
—
—
—
—
—
—
—
—
cases:1.48%
controls:0.17%
0
6
505
5023
—
—
—
—
—
6
7
399
4060
Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
92687-3 [37020937]
—
1.0e+50
1.0e+50
1.0e+50
1.0e+50
—
2.2e+00
—
—
cases:3.17%
controls:0.00%
cases:4.75%
controls:0.00%
cases:0.99%
controls:0.00%
cases:1.99%
controls:0.00%
—
—
cases:1.48%
controls:0.17%
—
16
0
489
5029
24
0
481
5029
5
0
500
5029
10
0
493
5015
—
6
7
399
4060
Maternal care for (suspected) chromosomal abnormality in fetus
O35.1 [45606585]
-1.0e+50
—
—
—
—
—
2.2e+00
cases:0.00%
controls:0.14%
—
—
—
—
—
—
—
—
—
—
cases:1.48%
controls:0.17%
0
7
505
5022
—
—
—
—
—
6
7
399
4060
Change in faeces/bowel movements
D18 [2002000317]
—
—
—
—
—
—
2.2e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.48%
controls:0.17%
—
—
—
—
—
—
6
7
399
4060
Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
88928-7 [36305771]
—
1.0e+50
1.0e+50
1.0e+50
1.0e+50
—
2.2e+00
—
—
cases:3.17%
controls:0.00%
cases:4.75%
controls:0.00%
cases:0.99%
controls:0.00%
cases:1.99%
controls:0.00%
—
—
cases:1.48%
controls:0.17%
—
16
0
489
5029
24
0
481
5029
5
0
500
5029
10
0
493
5015
—
6
7
399
4060
Sicca syndrome [Sjögren]
M35.0 [45562711]
1.7e+00
—
—
—
—
—
2.2e+00
cases:1.19%
controls:0.22%
—
—
—
—
—
—
—
—
—
—
cases:1.48%
controls:0.17%
6
11
499
5018
—
—
—
—
—
6
7
399
4060
Chronic superficial gastritis
K29.3 [45596316]
2.2e+00
—
—
—
—
—
—
cases:1.19%
controls:0.14%
—
—
—
—
—
—
—
—
—
—
—
—
6
7
499
5022
—
—
—
—
—
—
Excessive, frequent and irregular menstruation
N92 [45755570]
—
-1.0e+50
—
—
—
—
2.1e+00
—
—
cases:0.00%
controls:0.12%
—
—
—
—
—
—
—
—
cases:1.73%
controls:0.22%
—
0
6
505
5023
—
—
—
—
7
9
398
4058
pH of Urine
2756-5 [3015736]
1.7e-01
9.3e-01
1.2e+00
—
—
6.3e-01
4.9e-01
cases:10.10%
controls:8.65%
cases:8.91%
controls:3.70%
cases:1.78%
controls:0.54%
—
—
—
—
cases:8.23%
controls:4.54%
cases:21.48%
controls:14.33%
51
435
454
4594
45
186
460
4843
9
27
496
5002
—
—
40
220
446
4628
87
583
318
3484
Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
21613-5 [3006093]
5.7e-01
3.3e-01
—
—
-1.0e+50
1.2e+00
9.1e-01
cases:5.35%
controls:3.10%
cases:1.98%
controls:1.43%
—
—
—
—
cases:0.00%
controls:0.14%
cases:2.88%
controls:0.93%
cases:8.40%
controls:3.57%
27
156
478
4873
10
72
495
4957
—
—
0
7
503
5008
14
45
472
4803
34
145
371
3922
Haptoglobin [Mass/volume] in Serum or Plasma
4542-7 [3012336]
—
2.1e+00
—
—
—
1.5e+00
1.2e+00
—
—
cases:1.39%
controls:0.18%
—
—
—
—
—
—
cases:1.23%
controls:0.27%
cases:2.72%
controls:0.84%
—
7
9
498
5020
—
—
—
6
13
480
4835
11
34
394
4033
doxycycline; oral, parenteral
J01AA02 [21602800]
1.3e-01
8.1e-01
1.1e+00
—
—
6.4e-01
6.0e-01
cases:18.61%
controls:16.72%
cases:9.70%
controls:4.57%
cases:1.58%
controls:0.54%
—
—
—
—
cases:8.64%
controls:4.76%
cases:22.47%
controls:13.72%
94
841
411
4188
49
230
456
4799
8
27
497
5002
—
—
42
231
444
4617
91
558
314
3509
Syncope and collapse
R55 [45568141]
5.7e-01
—
—
—
—
2.0e+00
4.8e-01
cases:1.78%
controls:1.01%
—
—
—
—
—
—
—
—
cases:1.85%
controls:0.25%
cases:1.98%
controls:1.23%
9
51
496
4978
—
—
—
—
9
12
477
4836
8
50
397
4017
Benign neoplasm: Stomach
D13.1 [45586087]
2.0e+00
—
—
—
—
—
—
cases:1.19%
controls:0.16%
—
—
—
—
—
—
—
—
—
—
—
—
6
8
499
5021
—
—
—
—
—
—
25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
68438-1 [40771025]
4.3e-01
8.0e-01
9.2e-01
—
6.1e-01
6.8e-01
5.3e-01
cases:12.87%
controls:8.75%
cases:11.09%
controls:5.29%
cases:1.78%
controls:0.72%
—
—
cases:1.39%
controls:0.76%
cases:10.70%
controls:5.71%
cases:23.70%
controls:15.47%
65
440
440
4589
56
266
449
4763
9
36
496
4993
—
7
38
496
4977
52
277
434
4571
96
629
309
3438
Functional dyspepsia
K30 [45591584]
8.6e-01
1.2e+00
—
—
—
2.0e+00
8.3e-01
cases:2.77%
controls:1.19%
cases:1.58%
controls:0.48%
—
—
—
—
—
—
cases:2.26%
controls:0.31%
cases:3.70%
controls:1.65%
14
60
491
4969
8
24
497
5005
—
—
—
11
15
475
4833
15
67
390
4000
Office Visit
OMOP4822458 [581477]
7.4e-02
7.8e-01
—
1.0e+50
2.0e+00
2.4e-01
8.9e-02
cases:8.51%
controls:7.95%
cases:4.36%
controls:2.05%
—
—
cases:1.58%
controls:0.00%
cases:1.99%
controls:0.28%
cases:2.26%
controls:1.79%
cases:4.44%
controls:4.08%
43
400
462
4629
22
103
483
4926
—
8
0
497
5029
10
14
493
5001
11
87
475
4761
18
166
387
3901
Helicobacter pylori Ab [Units/volume] in Serum
7900-4 [3017895]
1.2e+00
2.0e+00
—
—
—
—
9.3e-01
cases:1.78%
controls:0.54%
cases:1.98%
controls:0.28%
—
—
—
—
—
—
—
—
cases:2.22%
controls:0.89%
9
27
496
5002
10
14
495
5015
—
—
—
—
9
36
396
4031
Result test/procedure
-60 [2002000131]
1.2e+00
—
—
—
—
—
2.0e+00
cases:0.99%
controls:0.30%
—
—
—
—
—
—
—
—
—
—
cases:1.73%
controls:0.25%
5
15
500
5014
—
—
—
—
—
7
10
398
4057
Acute atopic conjunctivitis
H10.1 [45605605]
—
—
—
—
—
—
2.0e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.73%
controls:0.25%
—
—
—
—
—
—
7
10
398
4057
Norovirus RNA [Presence] in Stool by NAA with probe detection
7974-9 [3008909]
—
2.3e+00
—
—
—
—
2.0e+00
—
—
cases:0.99%
controls:0.10%
—
—
—
—
—
—
—
—
cases:1.73%
controls:0.25%
—
5
5
500
5024
—
—
—
—
7
10
398
4057
Menopausal and other perimenopausal disorders
N95 [45582429]
1.7e+00
-1.0e+50
—
—
—
—
2.0e+00
cases:0.99%
controls:0.18%
cases:0.00%
controls:0.12%
—
—
—
—
—
—
—
—
cases:2.22%
controls:0.32%
5
9
500
5020
0
6
505
5023
—
—
—
—
9
13
396
4054
Emergency Medicine
93 [38004510]
7.2e-02
4.9e-01
1.6e+00
—
8.7e-01
4.9e-01
3.9e-01
cases:16.44%
controls:15.47%
cases:11.49%
controls:7.38%
cases:4.16%
controls:0.89%
—
—
cases:2.39%
controls:1.02%
cases:11.73%
controls:7.51%
cases:29.88%
controls:22.45%
83
778
422
4251
58
371
447
4658
21
45
484
4984
—
12
51
491
4964
57
364
429
4484
121
913
284
3154
Iron/Transferrin [Ratio] in Serum or Plasma
60517-0 [40763571]
3.3e-01
8.1e-01
—
—
—
9.8e-01
9.7e-01
cases:3.17%
controls:2.31%
cases:2.77%
controls:1.25%
—
—
—
—
—
—
cases:3.29%
controls:1.26%
cases:8.15%
controls:3.25%
16
116
489
4913
14
63
491
4966
—
—
—
16
61
470
4787
33
132
372
3935
Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
92695-6 [37019628]
—
—
1.0e+50
—
—
—
2.0e+00
—
—
—
—
cases:1.98%
controls:0.00%
—
—
—
—
—
—
cases:2.72%
controls:0.39%
—
—
10
0
495
5029
—
—
—
11
16
394
4051
Iron deficiency
E61.1 [45595821]
2.0e+00
2.0e+00
—
—
—
—
1.4e+00
cases:1.39%
controls:0.20%
cases:0.99%
controls:0.14%
—
—
—
—
—
—
—
—
cases:1.73%
controls:0.42%
7
10
498
5019
5
7
500
5022
—
—
—
—
7
17
398
4050
Headache
R51.80 [2000503603]
8.7e-01
4.6e-01
—
—
—
6.4e-01
1.1e+00
cases:4.55%
controls:1.97%
cases:1.19%
controls:0.76%
—
—
—
—
—
—
cases:1.44%
controls:0.76%
cases:5.93%
controls:2.14%
23
99
482
4930
6
38
499
4991
—
—
—
7
37
479
4811
24
87
381
3980
Chest pain, unspecified
R07.4 [45558450]
6.5e-01
1.5e-01
—
—
-1.0e+50
1.2e+00
7.5e-01
cases:5.74%
controls:3.08%
cases:1.78%
controls:1.53%
—
—
—
—
cases:0.00%
controls:0.20%
cases:3.09%
controls:0.99%
cases:8.15%
controls:4.01%
29
155
476
4874
9
77
496
4952
—
—
0
10
503
5005
15
48
471
4800
33
163
372
3904
Paraesthesia of skin
R20.2 [45568120]
5.6e-01
1.9e+00
—
—
—
—
8.5e-01
cases:1.39%
controls:0.80%
cases:1.58%
controls:0.24%
—
—
—
—
—
—
—
—
cases:2.22%
controls:0.96%
7
40
498
4989
8
12
497
5017
—
—
—
—
9
39
396
4028
Fear of other disease NOS
A27 [2002000161]
7.9e-01
—
—
—
—
—
1.9e+00
cases:1.39%
controls:0.64%
—
—
—
—
—
—
—
—
—
—
cases:2.22%
controls:0.34%
7
32
498
4997
—
—
—
—
—
9
14
396
4053
Myeloperoxidase IgG Ab [Units/volume] in Serum
48404-8 [3049804]
—
1.9e+00
—
—
—
—
1.8e+00
—
—
cases:1.19%
controls:0.18%
—
—
—
—
—
—
—
—
cases:1.98%
controls:0.32%
—
6
9
499
5020
—
—
—
—
8
13
397
4054
metoclopramide; oral, parenteral, rectal
A03FA01 [21600484]
8.0e-02
3.6e-01
—
—
—
1.0e+00
7.9e-01
cases:4.36%
controls:4.04%
cases:1.98%
controls:1.39%
—
—
—
—
—
—
cases:3.70%
controls:1.34%
cases:7.41%
controls:3.52%
22
203
483
4826
10
70
495
4959
—
—
—
18
65
468
4783
30
143
375
3924
Anaemia, unspecified
D64.9 [45600610]
—
1.8e+00
—
—
—
—
1.2e+00
—
—
cases:1.58%
controls:0.26%
—
—
—
—
—
—
—
—
cases:2.72%
controls:0.86%
—
8
13
497
5016
—
—
—
—
11
35
394
4032
epinephrine; parenteral
C01CA24 [21600303]
9.5e-01
1.4e+00
—
—
—
1.8e+00
1.0e+00
cases:2.57%
controls:1.01%
cases:1.39%
controls:0.34%
—
—
—
—
—
—
cases:2.06%
controls:0.35%
cases:3.21%
controls:1.20%
13
51
492
4978
7
17
498
5012
—
—
—
10
17
476
4831
13
49
392
4018
epinephrine
S01EA01 [21603673]
9.5e-01
1.4e+00
—
—
—
1.8e+00
1.0e+00
cases:2.57%
controls:1.01%
cases:1.39%
controls:0.34%
—
—
—
—
—
—
cases:2.06%
controls:0.35%
cases:3.21%
controls:1.20%
13
51
492
4978
7
17
498
5012
—
—
—
10
17
476
4831
13
49
392
4018
Chromogranin A [Moles/volume] in Serum or Plasma
25587-7 [3014702]
—
—
—
—
—
—
1.8e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.73%
controls:0.30%
—
—
—
—
—
—
7
12
398
4055
Proteinase 3 Ab [Units/volume] in Serum
6968-2 [3009445]
—
1.8e+00
—
—
—
—
1.3e+00
—
—
cases:1.39%
controls:0.24%
—
—
—
—
—
—
—
—
cases:1.98%
controls:0.54%
—
7
12
498
5017
—
—
—
—
8
22
397
4045
Cyclic citrullinated peptide Ab [Units/volume] in Serum
53027-9 [3041942]
4.1e-01
1.0e+00
—
—
—
5.5e-01
7.2e-01
cases:5.35%
controls:3.60%
cases:3.37%
controls:1.21%
—
—
—
—
—
—
cases:1.85%
controls:1.07%
cases:8.89%
controls:4.52%
27
181
478
4848
17
61
488
4968
—
—
—
9
52
477
4796
36
184
369
3883
Monitored bed care
WX892 [2001310850]
7.9e-01
—
—
—
—
—
1.8e+00
cases:1.39%
controls:0.64%
—
—
—
—
—
—
—
—
—
—
cases:1.98%
controls:0.34%
7
32
498
4997
—
—
—
—
—
8
14
397
4053
pantoprazole; oral, parenteral
A02BC02 [21600097]
6.4e-01
6.3e-01
6.0e-01
—
3.5e-01
4.0e-01
4.9e-01
cases:26.14%
controls:15.79%
cases:15.64%
controls:8.99%
cases:2.97%
controls:1.65%
—
—
cases:2.39%
controls:1.69%
cases:12.76%
controls:8.93%
cases:26.91%
controls:18.44%
132
794
373
4235
79
452
426
4577
15
83
490
4946
—
12
85
491
4930
62
433
424
4415
109
750
296
3317
IgM [Mass/volume] in Serum or Plasma
2472-9 [3028026]
-1.0e-01
8.0e-01
—
—
—
1.8e+00
8.6e-01
cases:1.19%
controls:1.31%
cases:1.19%
controls:0.54%
—
—
—
—
—
—
cases:2.67%
controls:0.47%
cases:2.47%
controls:1.06%
6
66
499
4963
6
27
499
5002
—
—
—
13
23
473
4825
10
43
395
4024
Special examination, unspecified
Z01.9 [45576123]
-1.0e+50
—
—
—
—
—
1.7e+00
cases:0.00%
controls:0.48%
—
—
—
—
—
—
—
—
—
—
cases:2.47%
controls:0.44%
0
24
505
5005
—
—
—
—
—
10
18
395
4049
Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
546-2 [3024135]
7.0e-01
8.4e-01
—
—
—
1.0e+00
2.2e-01
cases:12.48%
controls:6.58%
cases:3.56%
controls:1.57%
—
—
—
—
—
—
cases:4.94%
controls:1.88%
cases:9.14%
controls:7.45%
63
331
442
4698
18
79
487
4950
—
—
—
24
91
462
4757
37
303
368
3764
ketotifen
S01GX08 [21605092]
—
-1.0e+50
—
—
—
—
1.7e+00
—
—
cases:0.00%
controls:0.24%
—
—
—
—
—
—
—
—
cases:2.47%
controls:0.47%
—
0
12
505
5017
—
—
—
—
10
19
395
4048
Anoscopy
UJH02 [2001305182]
1.7e+00
—
—
—
—
—
—
cases:1.58%
controls:0.30%
—
—
—
—
—
—
—
—
—
—
—
—
8
15
497
5014
—
—
—
—
—
—
IgE [Units/volume] in Serum or Plasma
19113-0 [3005322]
4.2e-02
6.0e-01
—
—
—
1.7e+00
8.0e-01
cases:1.78%
controls:1.71%
cases:1.19%
controls:0.66%
—
—
—
—
—
—
cases:1.85%
controls:0.35%
cases:2.96%
controls:1.35%
9
86
496
4943
6
33
499
4996
—
—
—
9
17
477
4831
12
55
393
4012
More than one and less than three hours
ZXE10 [2001311401]
6.5e-01
-2.1e-02
—
—
-1.0e+50
9.0e-01
1.0e+00
cases:9.11%
controls:4.97%
cases:1.19%
controls:1.21%
—
—
—
—
cases:0.00%
controls:0.14%
cases:1.85%
controls:0.76%
cases:5.93%
controls:2.26%
46
250
459
4779
6
61
499
4968
—
—
0
7
503
5008
9
37
477
4811
24
92
381
3975
Palpitations/awareness of heart
K04 [2002000547]
6.0e-01
2.1e+00
—
—
—
—
1.6e+00
cases:1.19%
controls:0.66%
cases:0.99%
controls:0.12%
—
—
—
—
—
—
—
—
cases:2.47%
controls:0.49%
6
33
499
4996
5
6
500
5023
—
—
—
—
10
20
395
4047
Orthopedic Surgery
20 [38004465]
5.4e-01
6.1e-01
5.1e-01
—
8.1e-02
4.9e-01
4.8e-01
cases:18.61%
controls:11.81%
cases:8.12%
controls:4.57%
cases:1.39%
controls:0.84%
—
—
cases:0.99%
controls:0.92%
cases:7.41%
controls:4.68%
cases:20.99%
controls:14.14%
94
594
411
4435
41
230
464
4799
7
42
498
4987
—
5
46
498
4969
36
227
450
4621
85
575
320
3492
Emergency Room and Inpatient Visit
ERIP [262]
-3.4e-02
9.5e-02
1.6e+00
1.0e+50
—
2.8e-01
3.1e-01
cases:4.16%
controls:4.30%
cases:2.57%
controls:2.35%
cases:1.78%
controls:0.36%
cases:2.97%
controls:0.00%
—
—
cases:4.12%
controls:3.16%
cases:11.60%
controls:8.75%
21
216
484
4813
13
118
492
4911
9
18
496
5011
15
0
490
5029
—
20
153
466
4695
47
356
358
3711
Troponin T.cardiac [Mass/volume] in Serum or Plasma
6598-7 [3019800]
-5.5e-02
3.7e-01
1.6e+00
—
—
3.7e-01
3.7e-01
cases:6.53%
controls:6.88%
cases:4.16%
controls:2.92%
cases:1.58%
controls:0.32%
—
—
—
—
cases:3.91%
controls:2.72%
cases:11.85%
controls:8.48%
33
346
472
4683
21
147
484
4882
8
16
497
5013
—
—
19
132
467
4716
48
345
357
3722
Medical observation and evaluation for suspected diseases and conditions, ruled out
Z03 [45552058]
9.1e-01
1.3e+00
—
—
—
1.5e+00
1.6e+00
cases:2.57%
controls:1.05%
cases:1.39%
controls:0.40%
—
—
—
—
—
—
cases:1.44%
controls:0.31%
cases:4.94%
controls:1.03%
13
53
492
4976
7
20
498
5009
—
—
—
7
15
479
4833
20
42
385
4025
amitriptyline and psycholeptics
N06CA01 [21604789]
6.9e-01
—
—
—
—
1.1e+00
1.6e+00
cases:2.57%
controls:1.31%
—
—
—
—
—
—
—
—
cases:1.03%
controls:0.35%
cases:4.20%
controls:0.89%
13
66
492
4963
—
—
—
—
5
17
481
4831
17
36
388
4031
Simple examination of mouth
SAA01 [2001310274]
6.3e-02
1.9e-01
1.2e+00
—
—
1.5e-01
3.8e-01
cases:28.32%
controls:27.06%
cases:13.66%
controls:11.59%
cases:4.55%
controls:1.41%
—
—
—
—
cases:13.99%
controls:12.25%
cases:38.77%
controls:30.15%
143
1361
362
3668
69
583
436
4446
23
71
482
4958
—
—
68
594
418
4254
157
1226
248
2841
IgG [Mass/volume] in Serum or Plasma
2465-3 [3005719]
9.2e-02
7.0e-01
2.1e+00
—
—
1.5e+00
6.8e-01
cases:1.98%
controls:1.81%
cases:1.58%
controls:0.80%
cases:0.99%
controls:0.12%
—
—
—
—
cases:3.70%
controls:0.83%
cases:3.21%
controls:1.65%
10
91
495
4938
8
40
497
4989
5
6
500
5023
—
—
18
40
468
4808
13
67
392
4000
Diverticular disease of large intestine without perforation or abscess
K57.3 [45567316]
4.2e-01
1.1e+00
—
—
—
1.5e+00
5.9e-01
cases:2.97%
controls:1.97%
cases:1.98%
controls:0.68%
—
—
—
—
—
—
cases:3.09%
controls:0.70%
cases:4.44%
controls:2.51%
15
99
490
4930
10
34
495
4995
—
—
—
15
34
471
4814
18
102
387
3965
Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
3209-4 [3019250]
8.2e-01
—
—
—
—
—
1.5e+00
cases:1.39%
controls:0.62%
—
—
—
—
—
—
—
—
—
—
cases:2.47%
controls:0.57%
7
31
498
4998
—
—
—
—
—
10
23
395
4044
Other specified special examinations
Z01.8 [45581003]
1.6e-01
5.0e-01
—
—
-1.0e+50
1.5e+00
6.3e-01
cases:3.17%
controls:2.70%
cases:1.78%
controls:1.09%
—
—
—
—
cases:0.00%
controls:0.14%
cases:3.91%
controls:0.91%
cases:5.43%
controls:2.98%
16
136
489
4893
9
55
496
4974
—
—
0
7
503
5008
19
44
467
4804
22
121
383
3946
Other disorders of vitreous body
H43.8 [45533329]
1.5e+00
—
—
—
—
-1.0e+50
8.4e-01
cases:2.38%
controls:0.56%
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.29%
cases:1.98%
controls:0.86%
12
28
493
5001
—
—
—
—
0
14
486
4834
8
35
397
4032
Melanocytic naevi, unspecified
D22.9 [45571603]
1.5e+00
—
—
—
—
—
3.6e-01
cases:2.38%
controls:0.56%
—
—
—
—
—
—
—
—
—
—
cases:1.23%
controls:0.86%
12
28
493
5001
—
—
—
—
—
5
35
400
4032
Standard cardiac ultrasound examination
FM1AE [2001303278]
6.4e-01
1.0e+00
—
—
—
1.5e+00
6.8e-01
cases:3.37%
controls:1.81%
cases:2.38%
controls:0.86%
—
—
—
—
—
—
cases:2.67%
controls:0.64%
cases:3.95%
controls:2.04%
17
91
488
4938
12
43
493
4986
—
—
—
13
31
473
4817
16
83
389
3984
levofloxacin; inhalant, oral, parenteral
J01MA12 [21603019]
4.9e-01
1.4e+00
—
—
—
9.2e-01
6.4e-01
cases:2.77%
controls:1.71%
cases:1.98%
controls:0.48%
—
—
—
—
—
—
cases:1.03%
controls:0.41%
cases:3.95%
controls:2.11%
14
86
491
4943
10
24
495
5005
—
—
—
5
20
481
4828
16
86
389
3981
ABO and Rh group [Type] in Blood
882-1 [3003694]
-6.9e-02
6.7e-02
—
—
—
8.2e-01
6.2e-01
cases:6.73%
controls:7.18%
cases:2.97%
controls:2.78%
—
—
—
—
—
—
cases:4.73%
controls:2.15%
cases:12.10%
controls:6.91%
34
361
471
4668
15
140
490
4889
—
—
—
23
104
463
4744
49
281
356
3786
Throat symptom/complaint
R21 [2002000891]
6.8e-01
7.3e-01
—
—
—
1.0e+00
7.4e-01
cases:8.32%
controls:4.41%
cases:2.57%
controls:1.25%
—
—
—
—
—
—
cases:2.88%
controls:1.05%
cases:8.40%
controls:4.20%
42
222
463
4807
13
63
492
4966
—
—
—
14
51
472
4797
34
171
371
3896
Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
3255-7 [3016407]
—
—
—
—
—
—
1.4e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:2.47%
controls:0.61%
—
—
—
—
—
—
10
25
395
4042
Calcium [Moles/volume] in Serum or Plasma
2000-8 [3015377]
5.7e-01
8.3e-01
—
—
1.1e+00
6.6e-01
4.1e-01
cases:10.30%
controls:6.10%
cases:5.94%
controls:2.68%
—
—
—
—
cases:0.99%
controls:0.34%
cases:5.35%
controls:2.85%
cases:12.84%
controls:8.88%
52
307
453
4722
30
135
475
4894
—
—
5
17
498
4998
26
138
460
4710
52
361
353
3706
Irradiated enamel
K03.80 [2000502698]
1.2e+00
-1.0e+50
—
—
—
1.6e+00
1.4e+00
cases:2.18%
controls:0.70%
cases:0.00%
controls:0.22%
—
—
—
—
—
—
cases:1.23%
controls:0.25%
cases:2.72%
controls:0.69%
11
35
494
4994
0
11
505
5018
—
—
—
6
12
480
4836
11
28
394
4039
Concussion
S06.0 [45582805]
6.6e-01
—
—
—
—
—
1.3e+00
cases:1.98%
controls:1.03%
—
—
—
—
—
—
—
—
—
—
cases:4.44%
controls:1.20%
10
52
495
4977
—
—
—
—
—
18
49
387
4018
Ultrasound examination of upper part of abdomen
JN1AE [2001305517]
9.9e-01
—
—
—
—
—
1.3e+00
cases:1.58%
controls:0.60%
—
—
—
—
—
—
—
—
—
—
cases:2.72%
controls:0.74%
8
30
497
4999
—
—
—
—
—
11
30
394
4037
Migraine
N89 [2002000789]
5.1e-01
1.6e+00
—
—
—
—
1.3e+00
cases:0.99%
controls:0.60%
cases:0.99%
controls:0.20%
—
—
—
—
—
—
—
—
cases:2.72%
controls:0.74%
5
30
500
4999
5
10
500
5019
—
—
—
—
11
30
394
4037
Sinusitis acute/chronic
R75 [2002000943]
1.3e+00
—
—
—
—
-1.0e+50
—
cases:2.18%
controls:0.60%
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.10%
—
—
11
30
494
4999
—
—
—
—
0
5
486
4843
—
Laboratory test
15220000 [4034850]
1.9e-01
1.3e+00
—
—
-1.0e+50
7.7e-01
3.2e-01
cases:3.17%
controls:2.62%
cases:3.37%
controls:0.93%
—
—
—
—
cases:0.00%
controls:0.10%
cases:2.67%
controls:1.26%
cases:6.67%
controls:4.94%
16
132
489
4897
17
47
488
4982
—
—
0
5
503
5010
13
61
473
4787
27
201
378
3866
Prealbumin [Mass/volume] in Serum or Plasma
14338-8 [3013742]
-1.8e-01
5.8e-01
—
—
—
1.3e+00
6.0e-01
cases:1.58%
controls:1.89%
cases:1.98%
controls:1.11%
—
—
—
—
—
—
cases:2.47%
controls:0.68%
cases:3.46%
controls:1.92%
8
95
497
4934
10
56
495
4973
—
—
—
12
33
474
4815
14
78
391
3989
Cortisol [Moles/volume] in Serum or Plasma
14675-3 [3036481]
3.4e-01
7.4e-01
1.7e+00
—
—
1.3e+00
6.8e-01
cases:3.17%
controls:2.29%
cases:1.78%
controls:0.86%
cases:0.99%
controls:0.18%
—
—
—
—
cases:2.47%
controls:0.68%
cases:4.44%
controls:2.31%
16
115
489
4914
9
43
496
4986
5
9
500
5020
—
—
12
33
474
4815
18
94
387
3973
Nonallergic asthma
J45.1 [45557625]
1.3e+00
1.3e+00
—
—
2.3e+00
1.4e+00
8.4e-01
cases:2.77%
controls:0.78%
cases:1.39%
controls:0.38%
—
—
—
—
cases:0.99%
controls:0.10%
cases:1.23%
controls:0.31%
cases:1.98%
controls:0.86%
14
39
491
4990
7
19
498
5010
—
—
5
5
498
5010
6
15
480
4833
8
35
397
4032
rabeprazole; oral
A02BC04 [21600099]
-2.1e-02
5.4e-01
—
—
—
—
1.3e+00
cases:1.19%
controls:1.21%
cases:0.99%
controls:0.58%
—
—
—
—
—
—
—
—
cases:3.95%
controls:1.13%
6
61
499
4968
5
29
500
5000
—
—
—
—
16
46
389
4021
dexrabeprazole
A02BC07 [45893509]
-2.1e-02
5.4e-01
—
—
—
—
1.3e+00
cases:1.19%
controls:1.21%
cases:0.99%
controls:0.58%
—
—
—
—
—
—
—
—
cases:3.95%
controls:1.13%
6
61
499
4968
5
29
500
5000
—
—
—
—
16
46
389
4021
Acute vaginitis
N76.0 [45543891]
5.8e-01
1.4e+00
—
—
—
1.2e+00
1.3e+00
cases:1.58%
controls:0.89%
cases:1.19%
controls:0.30%
—
—
—
—
—
—
cases:1.03%
controls:0.31%
cases:3.95%
controls:1.13%
8
45
497
4984
6
15
499
5014
—
—
—
5
15
481
4833
16
46
389
4021
Sedation and analgesia
WX002 [2001310758]
5.1e-01
8.7e-01
—
—
—
1.0e+00
1.3e+00
cases:3.76%
controls:2.29%
cases:1.78%
controls:0.76%
—
—
—
—
—
—
cases:1.44%
controls:0.54%
cases:4.44%
controls:1.28%
19
115
486
4914
9
38
496
4991
—
—
—
7
26
479
4822
18
52
387
4015
Pulmonary Disease
29 [38004472]
5.0e-01
5.2e-01
1.1e+00
—
5.6e-01
6.4e-01
6.3e-01
cases:10.50%
controls:6.62%
cases:6.34%
controls:3.88%
cases:2.18%
controls:0.76%
—
—
cases:1.59%
controls:0.92%
cases:7.20%
controls:3.92%
cases:13.58%
controls:7.75%
53
333
452
4696
32
195
473
4834
11
38
494
4991
—
8
46
495
4969
35
190
451
4658
55
315
350
3752
Dry eye syndrome
H04.10 [2000502254]
5.6e-01
1.5e+00
—
—
—
1.3e+00
1.2e+00
cases:2.18%
controls:1.25%
cases:1.39%
controls:0.30%
—
—
—
—
—
—
cases:1.65%
controls:0.43%
cases:5.43%
controls:1.62%
11
63
494
4966
7
15
498
5014
—
—
—
8
21
478
4827
22
66
383
4001
Other oral or dental procedure
SXC05 [2001310586]
-2.1e-02
—
—
—
—
—
1.2e+00
cases:1.19%
controls:1.21%
—
—
—
—
—
—
—
—
—
—
cases:4.20%
controls:1.25%
6
61
499
4968
—
—
—
—
—
17
51
388
4016
Chronic rhinitis
J31.0 [45572165]
9.1e-01
—
—
—
—
—
1.2e+00
cases:2.38%
controls:0.97%
—
—
—
—
—
—
—
—
—
—
cases:3.95%
controls:1.18%
12
49
493
4980
—
—
—
—
—
16
48
389
4019
ECG with 12 standard connections
XF400 [2001303368]
5.9e-01
7.8e-01
—
—
—
—
1.2e+00
cases:2.97%
controls:1.67%
cases:0.99%
controls:0.46%
—
—
—
—
—
—
—
—
cases:2.96%
controls:0.89%
15
84
490
4945
5
23
500
5006
—
—
—
—
12
36
393
4031
Other somatoform disorders
F45.8 [45600750]
1.2e+00
—
—
—
—
—
1.1e+00
cases:3.76%
controls:1.13%
—
—
—
—
—
—
—
—
—
—
cases:2.96%
controls:0.96%
19
57
486
4972
—
—
—
—
—
12
39
393
4028
desonide
D07AB08 [21602112]
6.3e-01
—
—
—
—
1.1e+00
1.2e+00
cases:2.97%
controls:1.61%
—
—
—
—
—
—
—
—
cases:1.65%
controls:0.54%
cases:5.19%
controls:1.60%
15
81
490
4948
—
—
—
—
8
26
478
4822
21
65
384
4002
acetylsalicylic acid; oral, parenteral, rectal
N02BA01 [21604305]
4.1e-01
—
—
—
—
—
1.2e+00
cases:1.58%
controls:1.05%
—
—
—
—
—
—
—
—
—
—
cases:4.69%
controls:1.45%
8
53
497
4976
—
—
—
—
—
19
59
386
4008
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
LC2BE [2001306544]
5.4e-01
4.9e-01
—
—
—
8.9e-01
6.6e-01
cases:10.10%
controls:6.12%
cases:3.17%
controls:1.97%
—
—
—
—
—
—
cases:3.50%
controls:1.46%
cases:8.64%
controls:4.65%
51
308
454
4721
16
99
489
4930
—
—
—
17
71
469
4777
35
189
370
3878
Gastro-oesophageal reflux disease without oesophagitis
K21.9 [45538509]
1.2e+00
1.1e+00
—
—
—
9.7e-01
9.0e-01
cases:3.17%
controls:0.97%
cases:1.39%
controls:0.46%
—
—
—
—
—
—
cases:1.03%
controls:0.39%
cases:3.21%
controls:1.33%
16
49
489
4980
7
23
498
5006
—
—
—
5
19
481
4829
13
54
392
4013
aPTT in Platelet poor plasma by Coagulation assay
14979-9 [3018677]
-5.8e-02
6.1e-01
—
—
—
3.1e-01
1.2e+00
cases:2.57%
controls:2.72%
cases:1.78%
controls:0.97%
—
—
—
—
—
—
cases:1.23%
controls:0.91%
cases:8.40%
controls:2.70%
13
137
492
4892
9
49
496
4980
—
—
—
6
44
480
4804
34
110
371
3957
Intravenous general anesthesia
WX404 [2001310807]
5.5e-01
—
—
—
—
1.4e+00
1.2e+00
cases:5.35%
controls:3.16%
—
—
—
—
—
—
—
—
cases:1.44%
controls:0.37%
cases:3.70%
controls:1.16%
27
159
478
4870
—
—
—
—
7
18
479
4830
15
47
390
4020
Heartburn
R12 [45539318]
8.6e-01
—
—
—
—
—
1.2e+00
cases:2.18%
controls:0.93%
—
—
—
—
—
—
—
—
—
—
cases:3.46%
controls:1.11%
11
47
494
4982
—
—
—
—
—
14
45
391
4022
Otolaryngology
4 [38004449]
5.4e-01
4.1e-01
3.6e-01
—
1.2e+00
4.9e-01
6.1e-01
cases:15.64%
controls:9.78%
cases:4.75%
controls:3.20%
cases:0.99%
controls:0.70%
—
—
cases:1.99%
controls:0.60%
cases:5.56%
controls:3.49%
cases:16.79%
controls:9.86%
79
492
426
4537
24
161
481
4868
5
35
500
4994
—
10
30
493
4985
27
169
459
4679
68
401
337
3666
methylprednisolone; oral, parenteral
H02AB04 [21602732]
3.2e-01
1.2e+00
—
—
—
9.2e-01
1.1e+00
cases:2.18%
controls:1.59%
cases:1.58%
controls:0.48%
—
—
—
—
—
—
cases:1.03%
controls:0.41%
cases:3.46%
controls:1.16%
11
80
494
4949
8
24
497
5005
—
—
—
5
20
481
4828
14
47
391
4020
Palpitations
R00.2 [45558446]
7.5e-01
—
—
—
—
—
1.1e+00
cases:1.58%
controls:0.76%
—
—
—
—
—
—
—
—
—
—
cases:3.21%
controls:1.08%
8
38
497
4991
—
—
—
—
—
13
44
392
4023
Glucose [Presence] in Urine by Test strip
25428-4 [3009261]
1.7e-01
7.0e-01
1.0e+00
1.0e+50
3.6e-01
4.9e-01
4.1e-01
cases:13.27%
controls:11.43%
cases:10.89%
controls:5.71%
cases:1.98%
controls:0.74%
cases:0.99%
controls:0.00%
cases:1.19%
controls:0.84%
cases:10.29%
controls:6.58%
cases:26.42%
controls:19.30%
67
575
438
4454
55
287
450
4742
10
37
495
4992
5
0
500
5029
6
42
497
4973
50
319
436
4529
107
785
298
3282
Migraine without aura [common migraine]
G43.0 [45600784]
8.0e-01
8.7e-01
—
—
—
1.0e+00
1.1e+00
cases:2.18%
controls:0.99%
cases:0.99%
controls:0.42%
—
—
—
—
—
—
cases:1.44%
controls:0.54%
cases:3.70%
controls:1.25%
11
50
494
4979
5
21
500
5008
—
—
—
7
26
479
4822
15
51
390
4016
Issue of repeat prescription
Z76.0 [45542456]
5.9e-01
7.8e-01
-1.0e+50
—
-1.0e+50
1.1e+00
2.0e-01
cases:3.76%
controls:2.13%
cases:3.17%
controls:1.47%
cases:0.00%
controls:0.20%
—
—
cases:0.00%
controls:0.18%
cases:5.14%
controls:1.77%
cases:8.40%
controls:7.01%
19
107
486
4922
16
74
489
4955
0
10
505
5019
—
0
9
503
5006
25
86
461
4762
34
285
371
3782
Headache
N01 [2002000720]
5.2e-01
—
—
—
—
7.8e-01
1.1e+00
cases:3.17%
controls:1.91%
—
—
—
—
—
—
—
—
cases:1.03%
controls:0.47%
cases:5.68%
controls:1.97%
16
96
489
4933
—
—
—
—
5
23
481
4825
23
80
382
3987
Nitrite [Presence] in Urine by Test strip
5802-4 [3021601]
1.9e-01
6.9e-01
9.8e-01
1.0e+50
3.8e-01
4.9e-01
4.0e-01
cases:12.87%
controls:10.92%
cases:10.69%
controls:5.65%
cases:1.98%
controls:0.76%
cases:0.99%
controls:0.00%
cases:1.19%
controls:0.82%
cases:10.08%
controls:6.42%
cases:26.17%
controls:19.13%
65
549
440
4480
54
284
451
4745
10
38
495
4991
5
0
500
5029
6
41
497
4974
49
311
437
4537
106
778
299
3289
Standard MRI examination of brain with high intensity magnet
AA1BG [2001300112]
1.1e+00
—
—
—
—
—
9.8e-01
cases:2.97%
controls:1.01%
—
—
—
—
—
—
—
—
—
—
cases:3.46%
controls:1.33%
15
51
490
4978
—
—
—
—
—
14
54
391
4013
Bicarbonate [Moles/volume] in Serum or Plasma
1963-8 [3016293]
3.4e-01
—
—
—
—
—
1.1e+00
cases:1.39%
controls:0.99%
—
—
—
—
—
—
—
—
—
—
cases:3.70%
controls:1.28%
7
50
498
4979
—
—
—
—
—
15
52
390
4015
Observation for suspected disease or condition, unspecified
Z03.9 [45552062]
3.2e-01
6.1e-01
—
—
—
2.9e-01
1.1e+00
cases:3.56%
controls:2.60%
cases:1.78%
controls:0.97%
—
—
—
—
—
—
cases:1.23%
controls:0.93%
cases:5.93%
controls:2.09%
18
131
487
4898
9
49
496
4980
—
—
—
6
45
480
4803
24
85
381
3982
Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
24111-7 [3011371]
5.0e-01
4.9e-01
—
—
—
1.0e+00
1.1e+00
cases:3.56%
controls:2.19%
cases:1.58%
controls:0.97%
—
—
—
—
—
—
cases:2.06%
controls:0.76%
cases:7.65%
controls:2.78%
18
110
487
4919
8
49
497
4980
—
—
—
10
37
476
4811
31
113
374
3954
Repeated or continuing anesthesia shots throug a catheter
WX602 [2001310813]
—
-1.0e+50
—
—
—
1.3e+00
1.1e+00
—
—
cases:0.00%
controls:0.36%
—
—
—
—
—
—
cases:1.03%
controls:0.29%
cases:3.46%
controls:1.23%
—
0
18
505
5011
—
—
—
5
14
481
4834
14
50
391
4017
Toothache NOS
K08.80 [2000502799]
4.8e-01
—
—
—
—
—
1.1e+00
cases:1.98%
controls:1.23%
—
—
—
—
—
—
—
—
—
—
cases:3.46%
controls:1.23%
10
62
495
4967
—
—
—
—
—
14
50
391
4017
salbutamol; inhalant
R03AC02 [21603256]
3.4e-01
1.2e-01
6.5e-01
—
-1.0e+50
5.3e-01
5.2e-01
cases:20.59%
controls:15.59%
cases:8.91%
controls:7.97%
cases:2.18%
controls:1.15%
—
—
cases:0.00%
controls:1.30%
cases:12.35%
controls:7.63%
cases:24.20%
controls:15.93%
104
784
401
4245
45
401
460
4628
11
58
494
4971
—
0
65
503
4950
60
370
426
4478
98
648
307
3419
INR in Blood by Coagulation assay
34714-6 [3032080]
1.7e-01
3.1e-01
1.0e+00
—
3.2e-01
4.8e-01
3.0e-01
cases:9.70%
controls:8.33%
cases:6.34%
controls:4.73%
cases:2.97%
controls:1.07%
—
—
cases:1.39%
controls:1.02%
cases:6.58%
controls:4.17%
cases:13.58%
controls:10.45%
49
419
456
4610
32
238
473
4791
15
54
490
4975
—
7
51
496
4964
32
202
454
4646
55
425
350
3642
Angiography of heart and/or coronary arteries
FN1AC [2001302996]
-1.6e-01
—
—
—
—
1.5e+00
1.0e+00
cases:1.78%
controls:2.09%
—
—
—
—
—
—
—
—
cases:1.85%
controls:0.43%
cases:4.44%
controls:1.62%
9
105
496
4924
—
—
—
—
9
21
477
4827
18
66
387
4001
Lump/swelling localized
S04 [2002000969]
3.1e-01
—
—
—
—
8.2e-01
1.0e+00
cases:1.78%
controls:1.31%
—
—
—
—
—
—
—
—
cases:1.03%
controls:0.45%
cases:4.44%
controls:1.62%
9
66
496
4963
—
—
—
—
5
22
481
4826
18
66
387
4001
Single live birth
Z37.0 [45571346]
-5.4e-02
-1.0e+50
—
—
—
—
1.0e+00
cases:1.98%
controls:2.09%
cases:0.00%
controls:0.46%
—
—
—
—
—
—
—
—
cases:3.46%
controls:1.25%
10
105
495
4924
0
23
505
5006
—
—
—
—
14
51
391
4016
Sleep disturbance
P06 [2002000803]
7.6e-01
—
—
—
—
8.9e-01
1.0e+00
cases:2.97%
controls:1.41%
—
—
—
—
—
—
—
—
cases:1.65%
controls:0.68%
cases:5.93%
controls:2.19%
15
71
490
4958
—
—
—
—
8
33
478
4815
24
89
381
3978
Neurology
13 [38004458]
4.7e-01
6.2e-01
8.6e-01
—
2.5e-01
6.4e-01
5.5e-01
cases:13.27%
controls:8.69%
cases:6.53%
controls:3.64%
cases:1.58%
controls:0.68%
—
—
cases:0.99%
controls:0.78%
cases:6.79%
controls:3.71%
cases:14.32%
controls:8.78%
67
437
438
4592
33
183
472
4846
8
34
497
4995
—
5
39
498
4976
33
180
453
4668
58
357
347
3710
Anxiety disorder, unspecified
F41.9 [45542849]
6.5e-01
—
-1.0e+50
—
—
8.8e-01
1.0e+00
cases:2.97%
controls:1.57%
—
—
cases:0.00%
controls:0.26%
—
—
—
—
cases:2.26%
controls:0.95%
cases:5.93%
controls:2.26%
15
79
490
4950
—
0
13
505
5016
—
—
11
46
475
4802
24
92
381
3975
Transferrin [Mass/volume] in Serum or Plasma
3034-6 [3004789]
3.6e-01
7.6e-01
1.7e+00
—
—
8.6e-01
9.9e-01
cases:3.56%
controls:2.51%
cases:2.77%
controls:1.31%
cases:0.99%
controls:0.18%
—
—
—
—
cases:3.29%
controls:1.42%
cases:9.14%
controls:3.59%
18
126
487
4903
14
66
491
4963
5
9
500
5020
—
—
16
69
470
4779
37
146
368
3921
Surface analgesia on skin or mucosa
WX105 [2001310765]
9.9e-01
9.2e-01
—
—
—
—
5.1e-01
cases:3.76%
controls:1.43%
cases:0.99%
controls:0.40%
—
—
—
—
—
—
—
—
cases:2.22%
controls:1.35%
19
72
486
4957
5
20
500
5009
—
—
—
—
9
55
396
4012
temazepam; oral
N05CD07 [21604642]
9.7e-01
5.7e-01
—
—
—
8.2e-01
7.0e-01
cases:5.54%
controls:2.19%
cases:2.57%
controls:1.47%
—
—
—
—
—
—
cases:2.67%
controls:1.20%
cases:5.19%
controls:2.66%
28
110
477
4919
13
74
492
4955
—
—
—
13
58
473
4790
21
108
384
3959
tramadol; oral, parenteral, rectal
N02AX02 [21604298]
4.3e-01
1.7e-01
—
—
—
9.5e-01
5.3e-01
cases:9.70%
controls:6.52%
cases:2.97%
controls:2.53%
—
—
—
—
—
—
cases:4.73%
controls:1.88%
cases:10.37%
controls:6.39%
49
328
456
4701
15
127
490
4902
—
—
—
23
91
463
4757
42
260
363
3807
No disease
A97 [2002000230]
6.0e-01
5.1e-01
-1.0e+50
—
—
5.6e-01
9.5e-01
cases:4.16%
controls:2.33%
cases:1.58%
controls:0.95%
cases:0.00%
controls:0.12%
—
—
—
—
cases:1.44%
controls:0.83%
cases:7.65%
controls:3.10%
21
117
484
4912
8
48
497
4981
0
6
505
5023
—
—
7
40
479
4808
31
126
374
3941
Chronic asthma and similar chronic obstructive pulmonary diseases
203 [2001600201]
9.5e-01
—
—
—
—
—
4.5e-01
cases:3.37%
controls:1.33%
—
—
—
—
—
—
—
—
—
—
cases:1.73%
controls:1.11%
17
67
488
4962
—
—
—
—
—
7
45
398
4022
Lactate [Moles/volume] in Serum or Plasma
2524-7 [3014111]
6.8e-01
—
—
—
—
—
9.5e-01
cases:1.78%
controls:0.91%
—
—
—
—
—
—
—
—
—
—
cases:4.20%
controls:1.67%
9
46
496
4983
—
—
—
—
—
17
68
388
3999
Abdominal CT examination
JN3AD [2001305554]
—
—
—
—
—
1.2e+00
9.5e-01
—
—
—
—
—
—
—
—
—
—
cases:1.44%
controls:0.43%
cases:4.20%
controls:1.67%
—
—
—
—
—
7
21
479
4827
17
68
388
3999
Dizziness and giddiness
R42 [45568132]
9.5e-01
4.5e-01
—
—
—
7.9e-01
1.2e-01
cases:5.35%
controls:2.15%
cases:1.58%
controls:1.01%
—
—
—
—
—
—
cases:1.85%
controls:0.85%
cases:4.20%
controls:3.74%
27
108
478
4921
8
51
497
4978
—
—
—
9
41
477
4807
17
152
388
3915
Left side
ZXA05 [2001311347]
4.7e-01
—
—
—
—
—
9.4e-01
cases:3.76%
controls:2.39%
—
—
—
—
—
—
—
—
—
—
cases:4.69%
controls:1.89%
19
120
486
4909
—
—
—
—
—
19
77
386
3990
Lumbar and other intervertebral disc disorders with radiculopathy
M51.1 [45562747]
9.3e-01
—
—
—
—
—
5.0e-01
cases:3.37%
controls:1.35%
—
—
—
—
—
—
—
—
—
—
cases:3.21%
controls:1.97%
17
68
488
4961
—
—
—
—
—
13
80
392
3987
oxycodone; oral, parenteral
N02AA05 [21604260]
8.4e-02
8.2e-01
—
—
—
4.3e-01
9.2e-01
cases:1.19%
controls:1.09%
cases:0.99%
controls:0.44%
—
—
—
—
—
—
cases:1.23%
controls:0.80%
cases:4.69%
controls:1.92%
6
55
499
4974
5
22
500
5007
—
—
—
6
39
480
4809
19
78
386
3989
12 lead EKG panel
34534-8 [3044889]
3.0e-01
6.5e-02
5.9e-01
—
2.8e-01
5.1e-01
4.1e-01
cases:22.18%
controls:17.42%
cases:9.70%
controls:9.15%
cases:1.78%
controls:0.99%
—
—
cases:1.39%
controls:1.06%
cases:13.17%
controls:8.37%
cases:30.37%
controls:22.45%
112
876
393
4153
49
460
456
4569
9
50
496
4979
—
7
53
496
4962
64
406
422
4442
123
913
282
3154
Hand Surgery
40 [38004480]
6.7e-01
3.8e-01
-1.0e+50
—
—
—
9.1e-01
cases:4.95%
controls:2.59%
cases:1.39%
controls:0.95%
cases:0.00%
controls:0.14%
—
—
—
—
—
—
cases:5.93%
controls:2.48%
25
130
480
4899
7
48
498
4981
0
7
505
5022
—
—
—
24
101
381
3966
Exposure to unspecified factor
X59 [45756412]
9.0e-01
4.8e-01
—
—
—
4.5e-01
4.7e-01
cases:4.95%
controls:2.07%
cases:0.99%
controls:0.62%
—
—
—
—
—
—
cases:1.03%
controls:0.66%
cases:4.20%
controls:2.66%
25
104
480
4925
5
31
500
4998
—
—
—
5
32
481
4816
17
108
388
3959
duloxetine; oral
N06AX21 [21604749]
9.0e-01
2.2e-01
—
—
—
5.7e-01
4.2e-01
cases:3.76%
controls:1.57%
cases:1.19%
controls:0.95%
—
—
—
—
—
—
cases:1.85%
controls:1.05%
cases:2.96%
controls:1.97%
19
79
486
4950
6
48
499
4981
—
—
—
9
51
477
4797
12
80
393
3987
Hand/finger symptom/complaint
L12 [2002000636]
2.6e-01
4.7e-01
-1.0e+50
—
—
4.6e-01
9.0e-01
cases:3.17%
controls:2.47%
cases:1.39%
controls:0.87%
cases:0.00%
controls:0.10%
—
—
—
—
cases:1.23%
controls:0.78%
cases:5.93%
controls:2.51%
16
124
489
4905
7
44
498
4985
0
5
505
5024
—
—
6
38
480
4810
24
102
381
3965
Blood type and Crossmatch panel - Blood
34531-4 [3044640]
2.2e-01
3.3e-01
—
—
1.8e+00
5.3e-01
9.0e-01
cases:8.32%
controls:6.78%
cases:3.37%
controls:2.45%
—
—
—
—
cases:1.19%
controls:0.20%
cases:4.12%
controls:2.48%
cases:14.07%
controls:6.27%
42
341
463
4688
17
123
488
4906
—
—
6
10
497
5005
20
120
466
4728
57
255
348
3812

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
262
690
6.08
100.64
2.6
2.6
71.09
106.39
ug/g
2.16
218
547
88
124
8.18
60.98
1.3
1.2
—
—
—
0
0
112
243
5.47
50.46
1.5
1.2
—
—
—
0
0
290
1309
3.42
46.74
1.6
1.3
2.06
1.78
u/ml
0.08
54
341
166
530
3.98
45.51
1.3
1.3
—
—
—
0
0
271
1196
3.37
44.93
1.7
1.5
2.07
2.24
g/l
0.99
139
756
149
461
4.00
42.45
1.2
1.2
—
—
—
0
0
71
123
6.43
40.26
1.6
1.3
288.31
304.66
ug/g
0.27
52
64
319
1687
2.97
36.53
6.1
6.6
—
—
—
0
0
390
2459
2.77
29.42
7.1
6.4
54.38
56.91
%
4.55
378
2351
414
2698
2.84
29.13
7.0
6.5
2.10
1.98
e9/l
0.26
342
2390
392
2486
2.76
29.09
7.4
6.5
30.24
28.58
%
2.48
377
2376
155
615
3.07
28.84
1.3
1.2
—
—
—
0
0
406
2638
2.78
28.40
7.1
6.5
0.56
0.56
e9/l
0.07
320
2279
383
2431
2.68
27.85
7.4
6.6
8.66
8.64
%
0.04
367
2287
405
2646
2.74
27.70
7.1
6.5
0.04
0.04
e9/l
0.16
320
2283
381
2424
2.65
27.37
7.4
6.6
0.74
0.69
%
1.06
364
2269
125
455
3.22
26.79
2.0
2.4
29.47
36.31
u/l
1.15
112
390
380
2429
2.62
26.79
7.4
6.5
3.11
2.86
%
1.07
364
2283
411
2747
2.68
26.10
7.2
6.7
0.20
0.19
e9/l
0.52
339
2404
244
1280
2.56
26.04
2.7
2.0
—
—
—
0
0
102
342
3.40
24.89
1.5
1.2
—
—
—
0
0
418
2907
2.55
22.89
9.3
9.6
3.94
3.99
e9/l
0.07
339
2536
355
2301
2.39
22.68
10.3
10.7
0.00
0.00
e9/l
0.44
242
1862
480
3692
2.70
19.17
9.1
7.5
70.93
78.48
u/l
3.95
463
3488
223
1273
2.22
18.19
2.9
2.9
—
0.00
estimate
—
0
7
306
1994
2.13
17.60
5.2
4.6
36.60
36.47
g/l
0.16
289
1894
287
1826
2.13
17.57
4.2
3.6
23.12
83.11
e6/l
3.49
170
1202
367
2602
2.11
16.40
4.2
3.1
87.92
96.75
ug/l
0.45
351
2462
223
1322
2.11
16.11
3.3
2.9
0.20
0.36
e6/l
1.32
138
932
157
822
2.25
15.45
3.0
2.7
0.45
0.97
e6/l
3.60
66
430
298
2038
1.95
13.81
2.4
2.0
93.78
96.32
pmol/l
0.39
157
1092
144
765
2.17
13.46
3.0
2.9
1.18
2.31
e6/l
2.68
53
376
59
208
3.04
13.01
2.4
2.4
—
—
—
0
0
114
559
2.29
12.92
2.5
2.8
8.82
6.70
umol/l
0.46
96
491
238
1540
1.92
12.74
3.4
3.0
34.58
55.25
e6/l
0.66
158
1133
338
2454
1.90
12.64
6.5
6.4
12.07
10.83
umol/l
0.84
323
2347
197
1237
1.89
11.27
2.8
2.2
2.48
2.78
mg/l
1.16
174
1077
282
1981
1.82
11.25
2.2
2.1
—
—
—
0
0
225
1489
1.83
10.80
5.5
6.0
—
—
—
0
0
314
2296
1.80
10.80
2.9
2.4
79.57
75.23
nmol/l
1.89
287
2109
152
890
1.96
10.64
2.7
2.7
2.42
2.44
mmol/l
1.36
133
802
192
1218
1.86
10.51
3.6
3.4
—
0.09
—
0
11
135
778
1.96
9.81
2.8
2.3
14.61
13.77
umol/l
0.50
129
725
209
1386
1.79
9.75
3.6
3.8
7.39
7.40
ph
1.71
140
957
421
3446
1.80
9.03
5.7
4.1
—
2.90
—
0
9
125
723
1.93
8.92
2.8
2.3
2.33
2.39
g/l
0.55
115
666
550
4974
2.87
8.57
18.3
13.1
21.86
21.86
mg/l
0.00
446
3993
231
1646
1.67
7.96
3.0
3.0
2.35
2.36
mmol/l
0.29
213
1508
302
2323
1.62
7.55
6.7
7.1
1.21
1.21
mmol/l
0.04
276
2021
276
2081
1.62
7.46
5.3
6.6
1.21
1.22
mmol/l
0.17
266
1934
83
443
2.02
7.40
1.4
1.5
—
—
—
0
0
72
365
2.11
7.36
2.7
2.5
34.32
16.18
au/ml
—
10
33
35
127
2.87
7.36
1.1
1.2
—
—
—
0
0
68
339
2.14
7.26
1.4
1.3
36.59
34.46
au/ml
—
7
29
23
65
3.64
7.21
1.1
1.1
—
—
—
0
0
153
1009
1.70
6.90
2.6
2.4
5.76
7.00
e6/l
0.32
132
903
203
1449
1.62
6.69
2.9
2.4
55.65
64.99
u/l
1.22
193
1353
77
416
1.98
6.62
3.0
2.8
10.96
10.25
g/l
0.82
65
387
45
196
2.40
6.61
1.8
1.6
7.27
9.49
u/ml
0.34
12
44
281
2178
1.56
6.44
3.8
3.2
6.15
6.20
ph
0.28
136
1242
189
1344
1.60
6.25
1.8
1.6
21.68
20.74
nmol/l
0.43
168
1150
134
875
1.69
6.20
3.5
2.7
549.67
541.55
mosm/kgh2o
0.15
108
758
155
1052
1.64
6.19
1.3
1.3
27.76
33.63
iu/ml
0.32
33
314
14
21
6.80
6.06
1.1
1.1
—
—
—
0
0
542
4986
2.24
6.03
18.5
15.0
3.88
3.95
mmol/l
9.14
537
4879
541
4979
2.20
5.92
18.1
14.9
139.57
139.72
mmol/l
0.85
536
4884
30
115
2.70
5.73
1.4
1.3
254.45
229.95
u/ml
0.16
20
60
518
4710
1.90
5.64
6.4
5.2
1.73
1.84
mu/l
1.64
499
4412
40
181
2.30
5.42
1.6
2.3
1.29
1.37
g/l
0.21
33
164
36
159
2.35
5.16
1.1
1.1
0.48
9.63
eliau/ml
—
6
25
328
2710
1.48
5.10
4.5
3.6
0.00
0.57
estimate
0.51
54
536
62
341
1.92
5.07
1.7
1.7
1.19
1.41
g/l
0.75
56
320
323
2663
1.48
5.06
4.4
3.5
0.00
0.00
estimate
0.50
56
554
139
964
1.58
4.97
1.3
1.3
4.40
11.35
u/ml
1.39
49
367
159
1139
1.54
4.92
1.9
1.9
1.57
1.14
mg/l
0.58
119
879
96
608
1.69
4.92
1.4
1.4
—
—
—
0
0
126
856
1.60
4.91
3.7
3.7
1159.30
381.91
ng/l
0.32
87
603
115
764
1.63
4.90
1.4
1.4
538.18
438.30
titre
0.17
22
165
22
78
2.89
4.87
1.2
1.1
—
—
—
0
0
114
758
1.63
4.84
4.0
3.6
0.83
0.83
mmol/l
0.19
109
734
453
4027
1.56
4.73
5.0
4.3
14.45
14.59
pmol/l
0.66
428
3740
104
683
1.64
4.63
2.1
1.6
—
—
—
0
0
322
2692
1.44
4.45
4.5
3.5
0.00
0.00
estimate
-0.00
54
562
44
229
2.00
4.23
2.0
1.6
—
—
—
0
0
209
1626
1.44
4.21
2.6
2.2
—
—
—
0
0
401
3511
1.46
4.19
3.7
3.1
36.67
42.03
u/l
0.69
379
3344
16
52
3.14
4.11
1.1
1.2
—
—
—
0
0
52
290
1.87
4.10
1.1
1.1
—
—
—
0
0
221
1744
1.43
4.10
3.2
3.0
32.74
30.04
u/l
0.41
211
1651
11
22
5.07
4.02
5.1
2.2
0.55
0.77
index
0.60
11
22
15
48
3.18
3.95
1.1
1.1
—
—
—
0
0
16
54
3.02
3.87
1.6
1.3
—
—
—
0
0
75
474
1.67
3.87
2.6
3.3
1.52
1.77
%
3.10
64
437
39
201
2.01
3.87
1.1
1.3
—
—
—
0
0
143
1053
1.47
3.78
1.8
1.7
—
—
—
0
0
23
96
2.45
3.77
1.1
1.1
0.94
3.20
eliau/ml
—
9
45
20
78
2.62
3.75
1.2
1.0
—
—
—
0
0
284
2370
1.39
3.71
2.9
2.7
—
—
estimate
—
0
0
24
104
2.36
3.64
1.4
1.5
166.89
148.80
au/ml
—
9
28
39
208
1.94
3.53
1.4
1.3
—
—
—
0
0
252
2077
1.38
3.48
2.0
1.9
1.14
1.34
mmol/l
5.31
219
1785
25
113
2.27
3.46
4.2
2.7
3.50
1.76
index
0.84
14
58
25
115
2.23
3.33
1.4
1.5
—
—
—
0
0
10
23
4.40
3.32
1.0
1.2
158.08
149.06
nmol/l
—
10
23
53
322
1.71
3.18
2.9
3.4
4.49
4.59
pmol/l
0.39
42
284
323
2799
1.35
3.11
4.4
5.0
6.27
6.52
mmol/l
1.35
307
2601
59
376
1.63
2.97
1.8
1.5
—
—
—
0
0
60
387
1.61
2.89
1.2
1.3
185.07
219.62
u/ml
0.21
52
352
94
675
1.47
2.79
1.9
1.7
1053.02
1157.21
nmol/l
0.55
66
518
175
1401
1.36
2.79
2.3
2.1
121.01
239.32
u/l
1.71
166
1329
9
23
3.96
2.78
1.1
1.5
0.53
0.47
e9/l
—
9
23
15
62
2.46
2.56
2.3
1.3
—
—
—
0
0
40
240
1.72
2.55
1.3
2.1
7.72
7.57
iu/ml
—
5
55
17
75
2.30
2.53
3.7
2.8
2.54
3.00
mmol/l
—
8
45
12
45
2.70
2.46
1.0
1.1
—
—
—
0
0
62
420
1.53
2.45
1.1
1.3
137.81
146.96
u/ml
0.04
11
187
10
32
3.16
2.44
1.0
1.3
—
—
—
0
0
75
530
1.48
2.43
2.0
2.0
368.72
375.02
nmol/l
0.11
69
501
147
1169
1.34
2.41
4.3
3.9
—
—
—
0
0
19
90
2.15
2.41
1.4
1.1
—
—
—
0
0
107
810
1.39
2.39
2.6
1.7
—
—
—
0
0
95
705
1.42
2.38
2.0
2.4
29.89
29.11
s
0.84
95
691
499
4705
1.42
2.32
4.9
4.6
5.66
5.79
mmol/l
1.88
467
4372
196
1635
1.30
2.28
1.6
1.5
—
—
—
0
0
21
106
2.02
2.28
1.2
2.0
—
—
—
0
0
58
395
1.52
2.25
3.1
4.5
5.16
18.14
ug/l
0.63
40
323
151
1226
1.31
2.13
2.3
2.8
309.06
333.46
umol/l
2.95
134
1098
54
367
1.52
2.12
2.5
3.2
60.78
71.62
e9/l
1.93
35
273
9
31
2.93
2.08
1.2
1.1
—
—
—
0
0
86
647
1.39
2.00
1.2
1.2
—
—
—
0
0
5
11
4.57
1.94
1.2
2.9
0.64
0.60
mmol/l
—
5
11
21
113
1.89
1.94
2.1
1.8
—
—
—
0
0
38
244
1.60
1.92
1.4
1.5
0.15
0.26
mg/l
1.60
12
108
18
92
1.99
1.92
2.6
3.4
—
—
—
0
0
543
5235
1.54
1.91
14.4
10.9
24.45
25.91
u/l
1.67
535
5100
41
270
1.56
1.87
2.1
2.7
—
—
—
0
0
13
59
2.23
1.85
1.0
2.7
—
—
—
0
0
148
1221
1.28
1.84
2.9
3.3
687.58
1172.50
ng/l
2.94
120
1034
12
53
2.29
1.81
1.0
2.6
—
—
—
0
0
32
201
1.63
1.78
1.2
1.6
—
18.10
—
0
5
74
556
1.38
1.75
2.2
1.6
—
—
—
0
0
55
392
1.45
1.74
5.5
10.3
—
—
—
0
0
29
181
1.63
1.66
2.8
3.7
168.29
239.86
mg/l
0.96
14
84
8
31
2.60
1.66
1.9
1.5
188.88
181.38
pmol/l
—
8
31
14
69
2.05
1.66
1.1
1.3
—
72.54
—
0
5
537
5190
1.44
1.59
13.6
11.6
—
—
—
0
0
163
1385
1.25
1.57
3.2
2.8
—
—
—
0
0
37
249
1.52
1.57
1.1
1.1
—
—
—
0
0
16
85
1.91
1.56
1.3
1.4
0.83
0.56
nmol/l
0.46
16
80
6
21
2.88
1.51
1.0
1.0
—
—
—
0
0
29
189
1.56
1.43
1.4
1.4
1.13
1.30
mm
0.94
20
132
74
576
1.33
1.42
5.6
8.1
104.82
104.25
mmol/l
0.59
74
576
53
392
1.39
1.40
2.3
2.4
6.21
6.12
ph
0.31
34
261
26
166
1.59
1.39
1.6
1.8
0.94
2.91
ug/l
0.60
20
148
80
633
1.31
1.37
2.2
3.0
3.72
5.29
e9/l
1.57
72
560
6
23
2.62
1.37
1.0
1.1
138.00
190.46
mmol/24h
—
6
23
6
23
2.62
1.37
1.2
1.2
—
—
—
0
0
5
17
2.96
1.36
1.0
1.4
—
—
—
0
0
20
120
1.69
1.36
1.3
1.1
—
—
—
0
0
20
120
1.69
1.36
1.3
1.1
—
—
—
0
0
0
37
0.00
1.35
0.0
15.8
—
920.97
—
0
37
29
192
1.54
1.34
1.4
1.4
—
—
—
0
0
22
136
1.64
1.34
2.0
2.7
—
—
—
0
0
0
39
0.00
1.34
0.0
3.1
—
19.22
—
0
27
64
495
1.33
1.29
1.7
1.7
3.32
3.41
mmol/l
0.29
40
347
24
156
1.56
1.22
1.3
1.1
—
—
—
0
0
29
197
1.50
1.22
1.5
1.5
—
—
—
0
0
5
112
0.44
1.14
1.4
3.8
3.42
3.92
mmol/l
—
5
112
56
435
1.32
1.12
4.9
5.1
1.45
1.92
mmol/l
0.57
50
371
7
31
2.27
1.10
1.7
1.4
—
—
—
0
0
21
136
1.56
1.10
1.0
1.1
1.52
1.44
u/ml
0.03
13
66
19
120
1.60
1.10
1.3
1.9
142.67
192.31
e6/l
0.14
12
94
7
32
2.20
1.08
1.0
1.0
1785.00
1495.41
miu/ml
—
7
32
7
34
2.07
1.03
1.1
1.3
30.83
29.39
nmol/l
—
7
27
21
139
1.53
1.01
1.0
1.1
3.02
6.18
u/ml
0.76
16
83
190
1703
1.17
1.01
3.8
3.2
23.75
36.58
ng/l
1.25
101
1102
18
116
1.57
0.97
2.1
4.1
1.48
2.02
ratio
—
6
66
559
5491
1.44
0.96
27.1
20.4
4.48
4.52
e12/l
1.40
549
5383
11
62
1.79
0.94
1.4
1.4
—
—
—
0
0
559
5493
1.43
0.93
27.2
20.4
6.51
6.68
e9/l
0.67
550
5381
223
2035
1.16
0.93
4.2
3.4
0.00
0.01
estimate
1.15
51
468
18
118
1.54
0.92
1.2
1.9
43.00
17.00
e6/l
0.27
12
90
57
458
1.27
0.91
5.0
5.0
7.36
7.38
ph
0.90
32
264
14
86
1.64
0.91
4.1
3.7
6.45
7.81
pmol/l
0.44
14
86
31
228
1.38
0.90
1.5
1.4
293.40
254.99
miu/ml
0.20
15
117
11
63
1.76
0.90
3.7
2.6
—
—
—
0
0
87
735
1.22
0.90
3.2
3.1
0.52
0.73
ug/l
3.22
67
462
23
161
1.45
0.88
1.0
1.1
0.83
3.91
u/ml
1.80
18
92
8
43
1.87
0.87
1.1
1.1
119.38
111.53
pmol/l
—
8
43
41
319
1.31
0.85
1.5
1.6
—
—
—
0
0
6
31
1.95
0.84
2.3
3.2
730.33
710.03
u/ml
—
6
31
48
382
1.28
0.84
1.9
1.4
15.61
22.12
iu/l
1.13
39
316
33
249
1.34
0.84
1.4
1.5
69.23
58.49
ug/l
0.57
24
204
11
65
1.71
0.83
1.2
1.2
—
—
—
0
0
558
5490
1.38
0.82
27.2
20.4
253.69
255.58
e9/l
0.29
550
5396
471
4555
1.18
0.82
5.7
5.6
37.23
38.14
mmol/mol
1.83
449
4317
9
149
0.60
0.80
1.2
1.3
—
—
—
0
0
20
142
1.42
0.73
1.3
2.3
11.93
12.14
mg/l
0.05
20
133
19
136
1.41
0.67
1.1
1.1
1.45
2.01
u/ml
0.22
14
79
78
673
1.18
0.67
2.3
1.9
—
—
—
0
0
29
224
1.31
0.66
1.2
1.2
—
2.18
—
0
13
7
44
1.60
0.65
1.6
1.7
—
—
—
0
0
42
342
1.25
0.64
4.2
3.6
76.35
75.36
ng/l
0.03
37
311
12
79
1.53
0.63
1.3
1.3
18.73
76.72
mu/l
1.02
12
74
0
20
0.00
0.60
0.0
1.3
—
26.95
—
0
20
0
20
0.00
0.60
0.0
1.0
—
11.82
—
0
15
8
52
1.55
0.59
1.8
5.9
7.04
6.63
mmol/l
—
8
43
21
158
1.34
0.58
2.1
1.8
46.24
40.67
nmol/l
0.38
21
153
49
413
1.20
0.56
6.0
6.1
0.00
0.19
%
1.44
16
98
48
404
1.20
0.56
6.0
5.4
0.40
0.58
%
0.48
21
113
162
1494
1.12
0.56
4.0
3.0
0.00
0.06
estimate
0.60
50
457
10
65
1.55
0.56
1.2
1.2
18.05
25.16
ng/l
—
10
65
6
38
1.58
0.54
1.2
1.5
2.73
2.94
mg/l
—
6
38
497
4866
1.14
0.53
4.9
4.7
4.61
4.68
mmol/l
0.93
481
4584
39
324
1.22
0.52
2.9
2.2
4.63
7.25
ug/l
0.74
31
294
502
4926
1.14
0.48
5.8
5.3
2.72
2.77
mmol/l
0.66
486
4630
7
47
1.50
0.47
1.4
1.1
—
—
—
0
0
40
340
1.19
0.44
4.9
4.0
1.21
1.23
mmol/l
1.64
35
296
134
1240
1.10
0.44
4.9
4.7
—
—
—
0
0
21
166
1.27
0.44
1.1
1.2
—
—
—
0
0
198
2095
0.92
0.44
3.0
2.8
—
—
—
0
0
11
78
1.42
0.43
1.2
1.1
—
—
—
0
0
22
176
1.26
0.42
1.2
1.3
—
—
—
0
0
39
333
1.18
0.42
2.7
3.2
—
—
—
0
0
49
427
1.16
0.41
5.7
5.4
0.48
0.95
%
1.29
21
129
5
33
1.52
0.41
1.2
1.0
401.00
250.19
ng/l
—
5
21
5
34
1.47
0.40
3.2
3.5
427.20
799.00
mg
—
5
34
8
61
1.32
0.39
6.6
3.9
1.75
1.19
%
—
8
54
36
307
1.18
0.39
1.9
2.1
5976.49
6301.13
u/l
0.02
14
131
12
158
0.75
0.37
6.0
8.0
—
—
—
0
0
16
125
1.29
0.37
1.5
2.0
—
—
—
0
0
9
71
1.27
0.36
1.0
1.6
—
—
—
0
0
15
117
1.29
0.35
2.2
1.8
191.87
231.04
pmol/l
0.56
15
108
46
405
1.15
0.35
6.0
5.6
0.00
0.14
%
3.07
17
106
48
424
1.14
0.35
1.4
1.6
1022.75
1011.49
mu/l
0.03
39
349
24
200
1.21
0.34
1.4
1.4
8.73
9.82
u/l
0.16
17
149
6
45
1.34
0.34
1.7
1.4
—
—
—
0
0
6
45
1.34
0.34
2.7
13.1
8.47
11.11
%
—
6
45
6
47
1.28
0.32
1.3
1.1
—
—
—
0
0
13
101
1.29
0.32
1.0
1.1
11.92
8.61
u/ml
—
8
45
7
52
1.35
0.31
2.1
2.7
—
—
—
0
0
7
55
1.28
0.30
2.0
2.1
—
—
—
0
0
209
2008
1.06
0.28
13.9
11.5
1.21
1.19
inr
0.22
161
1645
12
94
1.28
0.28
1.0
1.1
0.19
0.54
u/ml
—
6
34
8
65
1.23
0.27
1.4
1.2
—
—
—
0
0
45
405
1.12
0.27
4.6
3.4
—
—
—
0
0
5
73
0.68
0.26
4.4
5.3
293.20
371.40
umol/l
—
5
65
5
75
0.66
0.26
1.6
1.3
—
—
—
0
0
6
82
0.73
0.24
1.5
1.5
—
—
—
0
0
12
97
1.24
0.23
2.3
7.1
47.25
62.43
%
1.93
12
97
21
242
0.86
0.22
2.8
1.9
0.00
0.01
estimate
—
5
87
0
10
0.00
0.21
0.0
1.0
—
7.23
—
0
10
0
12
0.00
0.21
0.0
8.7
—
4.98
—
0
12
45
412
1.10
0.21
4.4
4.0
7.32
7.34
ph
0.17
37
299
24
211
1.14
0.21
1.0
1.1
0.55
0.64
ratio
—
5
23
6
50
1.20
0.19
1.2
1.2
—
—
—
0
0
6
50
1.20
0.19
1.7
1.1
—
—
—
0
0
90
947
0.94
0.18
1.9
1.6
448.94
43489378.06
pmol/l
1.45
79
814
25
279
0.89
0.18
6.6
11.3
0.63
0.65
%
0.06
25
279
43
465
0.92
0.18
5.7
9.9
7.43
7.42
ph
0.53
18
262
12
101
1.19
0.16
1.7
1.2
2.79
2.75
ug/l
0.02
12
92
12
141
0.85
0.16
1.2
1.4
43.50
206.29
pmol/l
1.14
12
134
140
1449
0.96
0.16
3.9
4.0
8.60
9.43
mg/mmol
0.08
81
890
8
71
1.13
0.16
1.0
1.3
—
—
nmol/l
—
0
0
14
122
1.15
0.14
2.2
3.2
60.55
58.35
%
0.35
14
122
12
103
1.17
0.14
1.2
1.2
—
—
—
0
0
43
458
0.93
0.13
5.6
10.0
0.27
0.97
mmol/l
0.65
35
389
47
443
1.07
0.13
2.7
2.0
0.00
0.03
estimate
0.50
11
110
16
179
0.89
0.12
9.0
3.0
23.28
25.23
mmol/l
1.55
16
174
489
4857
1.04
0.11
4.9
4.6
1.49
1.47
mmol/l
0.56
473
4557
141
1446
0.97
0.11
4.5
3.6
0.00
0.01
estimate
0.88
55
529
21
228
0.92
0.10
3.0
6.6
—
—
—
0
0
5
45
1.11
0.10
1.0
1.0
—
—
—
0
0
10
87
1.15
0.09
1.0
1.2
—
—
—
0
0
10
87
1.15
0.09
2.6
3.5
3.87
4.07
e9/l
—
10
87
5
47
1.06
0.09
1.4
1.1
—
—
—
0
0
459
4619
0.97
0.09
4.1
4.0
1.13
1.25
mmol/l
5.20
436
4305
25
267
0.93
0.08
6.0
4.6
135.60
129.20
g/l
0.78
25
261
22
205
1.08
0.08
2.1
1.8
—
—
—
0
0
9
87
1.04
0.07
1.3
1.7
—
—
—
0
0
124
1217
1.02
0.06
3.5
3.4
1.02
1.02
kg/l
0.51
87
792
9
105
0.85
0.06
10.7
4.4
—
—
—
0
0
12
110
1.09
0.05
1.0
1.1
4.22
3.69
u/ml
—
6
56
28
268
1.05
0.04
1.5
1.6
—
—
—
0
0
19
180
1.06
0.04
7.5
3.7
24.90
24.87
mmol/l
0.01
19
173
27
281
0.96
0.04
2.6
2.5
57.69
94.75
u/ml
0.28
27
269
160
1616
0.99
0.03
3.1
3.2
7.96
7.93
mmol/l
0.02
143
1380
30
292
1.03
0.02
1.5
1.6
—
—
—
0
0
23
223
1.03
0.01
6.9
3.3
—
—
—
0
0
22
227
0.97
0.01
1.0
1.1
0.83
0.88
g/l
0.51
22
227
30
293
1.03
0.01
1.5
1.6
—
—
—
0
0
142
1413
1.01
0.00
3.1
3.3
56.46
55.26
mg/l
0.02
83
895
30
294
1.02
0.00
1.5
1.6
—
—
—
0
0
30
295
1.02
0.00
1.5
1.6
—
—
—
0
0
77
773
1.00
0.00
1.6
1.6
—
—
—
0
0
22
221
1.00
0.00
1.0
1.1
1.54
1.57
g/l
0.16
22
221
121
1211
1.00
0.00
5.6
5.2
1.60
2.57
ug/l
1.78
112
1089
0
8
0.00
0.00
0.0
1.6
—
—
—
0
0
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
0
8
0.00
0.00
0.0
21.5
—
0.42
—
0
8
7
69
1.01
0.00
2.0
2.1
—
—
—
0
0
0
8
0.00
0.00
0.0
1.5
—
59.63
—
0
8
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.3
—
33.83
—
0
6
0
6
0.00
0.00
0.0
2.5
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.1
—
—
—
0
0
6
67
0.89
-0.00
1.5
1.4
—
—
—
0
0
6
67
0.89
-0.00
1.5
1.4
—
—
—
0
0
6
67
0.89
-0.00
1.5
1.4
—
—
—
0
0
0
5
0.00
-0.00
0.0
3.0
—
1.60
—
0
5
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
72.66
—
0
5
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.6
—
4.52
—
0
5
0
5
0.00
-0.00
0.0
3.4
—
198.60
—
0
5
0
9
0.00
-0.00
0.0
2.4
—
6371.78
—
0
9
5
56
0.89
-0.00
2.2
2.2
30.80
33.45
pg
—
5
56
6
67
0.89
-0.00
1.5
1.4
—
—
—
0
0

Mortality – FinRegistry

↥

Association

Association between endpoint AB1_OTHER_PROTOZOAL and mortality.

Females

Parameter HR [95% CI] p-value
AB1_OTHER_PROTOZOAL 1.862 [1.43, 2.42] < 0.001
Birth year 0.997 [0.99, 1.01] 0.498

During the follow-up period (1.1.1998 — 31.12.2019), 137 out of 1428 females with AB1_OTHER_PROTOZOAL died.

Males

Parameter HR [95% CI] p-value
AB1_OTHER_PROTOZOAL 1.772 [1.39, 2.27] < 0.001
Birth year 0.987 [0.98, 1.0] 0.013

During the follow-up period (1.1.1998 — 31.12.2019), 128 out of 1146 males with AB1_OTHER_PROTOZOAL died.

Mortality risk

Mortality risk for people of age

years, who have AB1_OTHER_PROTOZOAL.

N-year risk Females Males
1 0.177% 0.302%
5 1.094% 1.879%
10 2.787% 4.981%
15 5.699% 9.485%
20 9.974% 15.868%

Relationships between endpoints

↥

Index endpoint: AB1_OTHER_PROTOZOAL – Other protozoal intestinal diseases

GWS hits: -

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data